Revised Listings for Growth Disorders and Weight Loss in Children, 19522-19530 [2015-08185]
Download as PDF
wreier-aviles on DSK5TPTVN1PROD with RULES
19522
Federal Register / Vol. 80, No. 70 / Monday, April 13, 2015 / Rules and Regulations
Peoria, IL, General Downing—Peoria
Intl, RNAV (GPS) RWY 4, Amdt 2
Peoria, IL, General Downing—Peoria
Intl, RNAV (GPS) RWY 13, Amdt 1A
Peoria, IL, General Downing—Peoria
Intl, RNAV (GPS) RWY 22, Amdt 1B
Peoria, IL, General Downing—Peoria
Intl, RNAV (GPS) RWY 31, Amdt 1B
Peoria, IL, General Downing—Peoria
Intl, Takeoff Minimums and Obstacle
DP, Amdt 2
Peoria, IL, Mount Hawley Auxiliary,
VOR–A, Amdt 4, CANCELED
Peoria, IL, Mount Hawley Auxiliary,
VOR/DME–A, Orig
Baton Rouge, LA, Baton Rouge
Metropolitan, Ryan Field, ILS OR
LOC RWY 13, Amdt 27E
Baton Rouge, LA, Baton Rouge
Metropolitan, Ryan Field, ILS OR
LOC RWY 22R, Amdt 11B
Baton Rouge, LA, Baton Rouge
Metropolitan, Ryan Field, NDB RWY
31, Amdt 2D
Baton Rouge, LA, Baton Rouge
Metropolitan, Ryan Field, RNAV
(GPS) RWY 31, Amdt 1D
Baton Rouge, LA, Baton Rouge
Metropolitan, Ryan Field, VOR RWY
4L, Amdt 17C
Baton Rouge, LA, Baton Rouge
Metropolitan, Ryan Field, VOR/DME
RWY 22R, Amdt 8H
Gonzales, LA, Louisiana Rgnl, RNAV
(GPS) RWY 17, Amdt 1B
Gonzales, LA, Louisiana Rgnl, VOR/
DME–A, Amdt 2A
Lafayette, LA, Lafayette Rgnl, RNAV
(GPS) RWY 29, Orig-B
New Roads, LA, False River Rgnl, LOC
RWY 36, Amdt 1A
New Roads, LA, False River Rgnl, NDB
RWY 36, Amdt 2A
New Roads, LA, False River Rgnl, RNAV
(GPS) RWY 18, Orig-A
New Roads, LA, False River Rgnl, RNAV
(GPS) RWY 36, Orig-A
New Roads, LA, False River Rgnl, VOR/
DME–A, Amdt 4A
Detroit, MI, Willow Run, Takeoff
Minimums and Obstacle DP, Amdt
10A
Minneapolis, MN, Minneapolis-St Paul
Intl/Wold-Chamberlain, ILS V RWY
35 (CONVERGING), Amdt 4
Minneapolis, MN, Minneapolis-St Paul
Intl/Wold-Chamberlain, ILS Z OR
LOC RWY 35, ILS Z RWY 35 (SA CAT
I), ILS Z RWY 35 (CAT II), ILS Z RWY
35 (CAT III), Amdt 4
Minneapolis, MN, Minneapolis-St Paul
Intl/Wold-Chamberlain, RNAV (GPS)
Z RWY 30L, Amdt 4
Minneapolis, MN, Minneapolis-St Paul
Intl/Wold-Chamberlain, RNAV (GPS)
Z RWY 35, Amdt 3
Minneapolis, MN, Minneapolis-St Paul
Intl/Wold-Chamberlain, RNAV (RNP)
Y RWY 12L, Orig
VerDate Sep<11>2014
15:35 Apr 10, 2015
Jkt 235001
Minneapolis, MN, Minneapolis-St Paul
Intl/Wold-Chamberlain, RNAV (RNP)
Y RWY 12R, Orig
Minneapolis, MN, Minneapolis-St Paul
Intl/Wold-Chamberlain, RNAV (RNP)
Y RWY 30L, Orig
New Ulm, MN, New Ulm Muni, NDB
RWY 15, Amdt 2A, CANCELED
New Ulm, MN, New Ulm Muni, NDB
RWY 33, Amdt 2A, CANCELED
Steele, MO, Steele Muni, RNAV (GPS)
RWY 18, Orig
Steele, MO, Steele Muni, RNAV (GPS)
RWY 36, Orig
Steele, MO, Steele Muni, Takeoff
Minimums and Obstacle DP, Orig
Billings, MT, Billings Logan Intl, ILS OR
LOC/DME RWY 28R, Amdt 2
Billings, MT, Billings Logan Intl, RNAV
(GPS) Y RWY 10L, Amdt 3
Billings, MT, Billings Logan Intl, RNAV
(GPS) Y RWY 28R, Amdt 3
Billings, MT, Billings Logan Intl, RNAV
(RNP) Z RWY 28R, Orig
Kalispell, MT, Glacier Park Intl, ILS OR
LOC RWY 2, Amdt 7
Ahoskie, NC, Tri-County, GPS RWY 1,
Orig, CANCELED
Ahoskie, NC, Tri-County, GPS RWY 19,
Orig, CANCELED
Ahoskie, NC, Tri-County, RNAV (GPS)
RWY 1, Orig
Ahoskie, NC, Tri-County, RNAV (GPS)
RWY 19, Orig
Ahoskie, NC, Tri-County, VOR/DME–A,
Amdt 6
Charlotte, NC, Charlotte/Douglas Intl,
ILS OR LOC RWY 18L, Amdt 8
Charlotte, NC, Charlotte/Douglas Intl,
ILS OR LOC RWY 18R, ILS RWY 18R
(SA CAT I), ILS RWY 18R (CAT II),
ILS RWY 18R (CAT III), Amdt 1
Charlotte, NC, Charlotte/Douglas Intl,
ILS OR LOC RWY 36L, ILS RWY 36L
(SA CAT I), ILS RWY 36L (CAT II),
ILS RWY 36L (CAT III), Amdt 1
Charlotte, NC, Charlotte/Douglas Intl,
ILS OR LOC RWY 36R, ILS RWY 36R
(SA CAT I), ILS RWY 36R (CAT II),
ILS RWY 36R (CAT III), Amdt 12
Charlotte, NC, Charlotte/Douglas Intl,
RNAV (GPS) Y RWY 18L, Amdt 4
Charlotte, NC, Charlotte/Douglas Intl,
RNAV (GPS) Y RWY 18R, Amdt 1
Charlotte, NC, Charlotte/Douglas Intl,
RNAV (GPS) Y RWY 36L, Amdt 1
Charlotte, NC, Charlotte/Douglas Intl,
RNAV (GPS) Y RWY 36R, Amdt 4
Smithfield, NC, Johnston Regional, ILS
OR LOC Y RWY 3, Orig
Smithfield, NC, Johnston Regional, ILS
OR LOC Z RWY 3, Amdt 2
Smithfield, NC, Johnston Regional, NDB
RWY 3, Amdt 2
Smithfield, NC, Johnston Regional,
RNAV (GPS) RWY 3, Amdt 1
Smithfield, NC, Johnston Regional,
RNAV (GPS) RWY 21, Amdt 1
Smithfield, NC, Johnston Regional,
Takeoff Minimums and Obstacle DP,
Amdt 4
PO 00000
Frm 00012
Fmt 4700
Sfmt 4700
Curtis, NE., Curtis Muni, RNAV (GPS)
RWY 12, Orig
Curtis, NE., Curtis Muni, RNAV (GPS)
RWY 30, Orig
Curtis, NE., Curtis Muni, Takeoff
Minimums and Obstacle DP, Orig
Oklahoma City, OK, Wiley Post, RNAV
(GPS) RWY 17L, Amdt 2A
Houston, TX, Houston Executive, RNAV
(GPS) RWY 18, Orig-A
Kingsville, TX, Kleberg County, NDB
RWY 13, Amdt 6, CANCELED
New Braunfels, TX, New Braunfels
Rgnl, RNAV (GPS) RWY 13, Amdt 1
New Braunfels, TX, New Braunfels
Rgnl, RNAV (GPS) RWY 31, Amdt 1
Price, UT, Carbon County Rgnl/Buck
Davis Field, RNAV (GPS) RWY 1,
Amdt 2
Siren, WI, Burnett County, RNAV (GPS)
RWY 5, Orig
Siren, WI, Burnett County, RNAV (GPS)
RWY 14, Orig
Siren, WI, Burnett County, RNAV (GPS)
RWY 23, Orig
Siren, WI, Burnett County, RNAV (GPS)
RWY 32, Orig
Siren, WI, Burnett County, VOR RWY 5,
Amdt 3
[FR Doc. 2015–08113 Filed 4–10–15; 8:45 am]
BILLING CODE 4910–13–P
SOCIAL SECURITY ADMINISTRATION
20 CFR Parts 404 and 416
[Docket No. SSA–2011–0081]
RIN 0960–AG28
Revised Listings for Growth Disorders
and Weight Loss in Children
Social Security Administration.
Final rule.
AGENCY:
ACTION:
This rule adopts, with one
change, the rule for evaluating growth
disorders in children we proposed in a
notice of proposed rulemaking (NPRM)
published in the Federal Register on
May 22, 2013. Several body systems in
the Listing of Impairments (listings)
contain listings for children based on
impairment of linear growth or weight
loss. We are replacing those listings
with new listings for low birth weight
(LBW) and failure to thrive; a new
listing for genitourinary impairments;
and revised listings for growth failure in
combination with a respiratory,
cardiovascular, digestive, or immune
system disorder. These revisions reflect
our program experience, advances in
medical knowledge, and comments we
received from medical experts and the
public.
DATES: This rule is effective June 12,
2015.
SUMMARY:
E:\FR\FM\13APR1.SGM
13APR1
Federal Register / Vol. 80, No. 70 / Monday, April 13, 2015 / Rules and Regulations
FOR FURTHER INFORMATION CONTACT:
Cheryl A. Williams, Office of Medical
Policy, Social Security Administration,
6401 Security Boulevard, Baltimore,
Maryland 21235–6401, (410) 965–1020.
For information on eligibility or filing
for benefits, call our national toll-free
number, 1–800–772–1213, or TTY 1–
800–325–0778, or visit our Internet site,
Social Security Online, at https://
www.socialsecurity.gov.
SUPPLEMENTARY INFORMATION:
Background
We are adopting, as final, the rule for
evaluating growth disorders in children
we proposed in an NPRM published in
the Federal Register on May 22, 2013 at
78 FR 30249. We made one addition to
this rule as the result of a public
comment suggesting we provide
guidance for evaluating LBW in
children born at less than 32 weeks
gestation or weighing less than 1325
grams. We revised the table in listing
100.04B to include 32 weeks in the
Gestational Age column because we
believe that this guidance is
appropriate.
The preamble to the NPRM discussed
the remaining changes from our current
rule and our reasons for proposing those
changes. To the extent that we are
adopting the proposed rule as
published, we are not repeating that
information here. Interested readers may
refer to the preamble to the NPRM,
available at https://www.regulations.gov
under docket number SSA–2011–0081.
wreier-aviles on DSK5TPTVN1PROD with RULES
Why are we revising the listings for
evaluating growth disorders in
children?
We are revising the listings for
evaluating growth disorders in children
to update the medical criteria, provide
more information on how we evaluate
growth disorders, reflect our program
experience, and address adjudicator
questions.
Public Comments on the NPRM
In the NPRM, we provided the public
with a 60-day comment period, which
ended on July 22, 2013. We received six
comments. The commenters included
state agencies that make disability
determinations for us, the National
Association of Disability Examiners,
medical organizations, such as the
American Academy of Pediatrics, and
advocacy groups, such as the Endocrine
Society. We carefully considered all of
the comments, summarized the
commenters’ views, and responded to
all of the significant issues that were
within the scope of this rule. Some
commenters noted provisions with
which they agreed and did not make
VerDate Sep<11>2014
15:35 Apr 10, 2015
Jkt 235001
suggestions for changes in those
provisions. We did not summarize or
respond to those comments.
Listing 100.04 Low Birth Weight in
Infants From Birth to Attainment of Age
1
Low Birth Weight
Comment: One commenter suggested
that we provide guidance in the listings
at 100.04A or 100.04B, or in the
introductory text at 100.00, on diaries
used to schedule continuing disability
reviews (CDR) for LBW infants. The
commenter believes that, while this
guidance is already in our internal
operating instructions, providing it in
the regulations would reduce the
number of incorrect diaries being set for
LBW cases.
Response: We did not adopt this
comment. In 100.00B, we include a
reference to our rule for CDRs for LBW
cases at § 416.990(b)(11). Additionally,
the Act requires, with one exception,
that we perform a CDR not later than 12
months after the birth of an infant
whose LBW is a contributing factor
material to the determination that the
infant is disabled. We will continue to
provide guidance on diaries for LBW
cases and cases involving other
disabling impairments in our internal
operating instructions. We do not
believe it is necessary to repeat this
guidance in the regulation.
Comment: One commenter expressed
concern that listing 100.04 suggests that
LBW is a disability. The commenter felt
that it should be clear that weight is ‘‘a
proxy measure for prematurity,
dysphagia, and other functional
impairments that are associated with
disabilities, rather than weight as a
disability itself.’’ The commenter did
not provide suggested language to
include in our rule.
Response: We did not adopt this
comment. We agree that, for the
purposes of listing 100.04, weight is a
proxy measure for disability in infants
from birth to the attainment of age 1.
However, we do not believe that
providing additional guidance is
necessary for the clarity of our rule. As
we noted in the preamble to the
proposed rule, we based listing 100.04
on sections 416.926a(m)(6) and (m)(7) of
our functional equivalence rule.1 Our
adjudicators have over 20 years of
experience evaluating claims filed on
behalf of children based on LBW under
our functional equivalence rule. In our
experience applying this rule, we have
not found that the type of guidance the
1 78
PO 00000
FR at 30350.
Frm 00013
Fmt 4700
Sfmt 4700
19523
commenter suggested is necessary in
order to apply the rule properly.
Evaluating Infants Born at 33 Weeks
Weighing Less Than 1325 Grams
Comment: One commenter suggested
that we add guidance for evaluating
infants who weigh between 1200 grams
and 1325 grams, and who are born at
gestational ages of 32 weeks or less.
Response: We partially adopted this
comment. We agree that it is appropriate
to provide guidance for evaluating LBW
in infants who are born at 32 weeks
gestational age. We revised the table in
100.04B to provide a birth weight value
of 1250 grams or less for the gestational
age of 32 weeks. However, we did not
provide birth weight values for
gestational ages less than 32 weeks. The
birth weight values that we would
provide for infants born at less than 32
weeks would be less than 1200 grams
and, thus, the birth weight would meet
the criterion in 100.04A.
Listing 100.05 Failure To Thrive in
Children From Birth to Attainment of
Age 3
Growth Measurements
Comment: One commenter
recommended including growth curves
in 100.05A to make administrative
processing for pediatricians easier.
Another commenter suggested that we
make determinations based on growth
measurements alone without requiring a
diagnosis of developmental delay.
Response: We did not adopt these
comments. In 100.05A, we require three
weight-for-length measurements or body
mass index (BMI)-for-age measurements
that are within a 12-month period, at
least 60-days apart, and less than the
third percentile on the appropriate table
in listing 105.08B.2. The adjudicator
making the disability determination
uses the information from growth curves
provided by the child’s pediatrician to
find the corresponding values on the
tables provided. We do not believe it is
necessary to include the growth curves
in the listing because our adjudicators
use the listing, rather than the
pediatrician who evaluates a child.
As we stated in the NPRM, our
program experience has shown that
growth failure alone is not disabling (78
FR at 30251). To meet the severity
requirements for listing 100.05B, the
child must have growth failure with a
developmental delay of the appropriate
severity required by the listing. Children
with growth failure without
developmental delay may be evaluated
in the appropriate body system of the
underlying condition causing the
growth failure.
E:\FR\FM\13APR1.SGM
13APR1
19524
Federal Register / Vol. 80, No. 70 / Monday, April 13, 2015 / Rules and Regulations
wreier-aviles on DSK5TPTVN1PROD with RULES
Developmental Testing
Comment: One commenter questioned
the requirement for two narrative
developmental reports in 100.05C and
the requirement that these two reports
be at least 120 days apart. This
commenter suggested that, if we keep
the requirement for two reports, we
should require a shorter period of either
30 or 60 days between them. Another
commenter also expressed concern
about the requirements for the evidence
of developmental delay. This
commenter was concerned about the
availability of these records from
providers.
Response: We did not adopt these
comments. In 100.05C, we require two
narrative developmental reports when a
report of a standardized developmental
assessment required by 100.05B is not
available. As we explained in the
NPRM, abnormal findings noted on
repeated examinations, and information
in narrative developmental reports, that
may include the results of
developmental screening tests, can
identify a child who is not developing
or achieving skills within expected
timeframes.2
We do not believe that 30 or 60 days
is enough time for these kinds of
changes to appear on testing. We believe
that 120 days is an appropriate period
for developmental testing to be
performed and to allow for any changes
in development to show on testing.
While we understand the
commenter’s concern about the
availability of evidence, we believe that,
for the children whose impairments we
evaluate under listing 100.05, evidence
generally will be available from
providers because these children are
likely to be identified, and subsequently
treated because of their identification,
by early intervention programs.
Comment: One commenter noted that
most early intervention programs use ‘‘a
25 percent delay criteria as opposed to
the two-thirds criteria’’ required in
100.05C. However, the commenter did
not provide any suggestions for
changing the criterion.
Response: We did not adopt this
comment. We recognize that early
intervention programs often use a 25
percent delay criterion to determine
eligibility for intervention services and
to identify the needed services. In
contrast, we evaluate a child’s delay to
determine whether the underlying
impairment is disabling because it
results in ‘‘marked and severe
functional limitations.’’ An impairment
results in ‘‘marked and severe
2 78
FR at 30251.
VerDate Sep<11>2014
15:35 Apr 10, 2015
functional limitations’’ only if it meets,
medically equals, or functionally equals
the listings. An impairment is of listinglevel severity if it results in ‘‘marked’’
limitations in two domains of
functioning or an ‘‘extreme’’ limitation
in one domain.3 The level of delay that
we require in 100.05C is consistent with
our definition of ‘‘marked limitation’’ in
§ 416.926a(e)(2)(ii).
Comment: One commenter expressed
concern about acceptable timeframes for
performing developmental testing in
relation to disability determinations
stated in 100.05B and 100.05C. The
commenter suggested that the testing to
establish the child’s current level of
development be performed within 6
months of adjudication.
Response: We partially adopted this
comment. We agree that evidence about
a child’s development must be recent
and current in relation to a disability
determination, and we have revised
listings 100.05B and 100.05C2 to clarify
this requirement. However, the facts in
a specific case determine whether the
evidence is current. Determining factors
include, but are not limited to, the age
of the child, the amount of delay, and
the developmental trajectory
documented over time. We are not
setting specific timeframes for when
developmental testing must be
performed, but we are specifying that
the evidence must reflect the child’s
current development.
Linear Growth
Comment: One commenter agreed
with our use of weight-for-length and
BMI-for-age charts to evaluate growth
failure, rather than of linear (height or
length) growth charts. The commenter
expressed concern, however, that an
underlying condition could cause a
child to have such profound growth
failure that BMI for the child’s age
would become normal, despite his or
her significant growth failure.
Response: We did not adopt this
comment. We understand the
commenter’s concerns that some
children may have underlying
conditions that cause linear growth
impairments while their BMI-for-age
measurements are normal. After
attainment of age 2, most children
without an underlying medical disorder
follow a growth trajectory that remains
fairly constant during childhood.
Our adjudicative experience has
shown that a declining linear growth
rate is not always indicative of a
disabling condition. Short stature,
length, or height below the third
percentile, in and of itself, is not a
3 See
Jkt 235001
PO 00000
20 CFR 416.926a(a).
Frm 00014
Fmt 4700
medically determinable impairment,
although it can be the result of a
medically determinable impairment. We
will evaluate children with growth
failure that does not meet the
requirements of listings 100.04 and
100.05 and is associated with a known
medically determinable impairment
under the affected body system.
Comment: One commenter was
concerned that, while the majority of
children over the age of 3 with growth
failure have signs and symptoms of an
underlying disorder in the respiratory,
cardiovascular, digestive, genitourinary,
or immune body system, some children
over the age of 3 will not. This
commenter suggested that we include
exceptions for conditions, such as
Turner syndrome (female
hypogonadism) and acquired growth
hormone deficiency, where growth
failure may be a significant component
of the disease process.
Response: We did not adopt this
comment. After a child attains age 3, we
will evaluate his or her impairment
under the affected body system. The two
examples provided by the commenter
are endocrine disorders. Although these
two disorders are not listed impairments
for children, they may rise to listinglevel severity because of their effects in
other body systems. As the commenter
explained, children with Turner
syndrome may experience
complications, such as heart disease, to
a degree that is disabling. We would
evaluate the complications under the
affected body system.
Listing 103.06 Growth Failure Due to
Any Chronic Respiratory Disorder
Comment: Two commenters were
concerned with the requirement for
oxygen supplementation in 103.06A.
The commenters noted that some
respiratory disorders, such as asthma,
bronchiectasis, and cystic fibrosis, could
result in listing-level growth failure
without requiring oxygen
supplementation.
Response: We did not adopt these
comments. We agree with the
commenters that some respiratory
disorders could result in listing-level
growth failure without requiring oxygen
supplementation; however, we did not
revise 103.06 as a result. We use other
listings, such as 103.02, 103.03, and
103.04, in the respiratory body system
to evaluate these disorders.4 We believe
that these respiratory listings, and our
functional equivalence rule for
evaluating disability in children,
4 See
Sfmt 4700
E:\FR\FM\13APR1.SGM
20 CFR part 404, subpart P, Appendix 1.
13APR1
Federal Register / Vol. 80, No. 70 / Monday, April 13, 2015 / Rules and Regulations
adequately address the disorders
referred to by the commenters.5
approval under the Paperwork
Reduction Act.
What is our authority to make rules
and set procedures for determining
whether a person is disabled under the
statutory definition?
(Catalog of Federal Domestic Assistance
Program Nos. 96.001, Social Security—
Disability Insurance; 96.002, Social
Security—Retirement Insurance; 96.004,
Social Security—Survivors Insurance; and
96.006, Supplemental Security Income).
The Act authorizes us to make rules
and regulations and to establish
necessary and appropriate procedures to
implement them.6
When will we use this final rule?
We will begin to use this final rule on
its effective date. We will continue to
use the current listings until the date
this final rule becomes effective. We
will apply the final rule to new
applications filed on or after the
effective date of the final rule and to
claims that are pending on or after the
effective date.7
How long will this final rule be
effective?
This final rule will remain in effect
for 5 years after the date it becomes
effective, unless we extend it or revise
and issue it again.
Regulatory Procedures
Executive Order 12866, as
Supplemented by Executive Order
13563
We consulted with the Office of
Management and Budget (OMB) and
determined that this final rule meets the
criteria for a significant regulatory
action under Executive Order 12866, as
supplemented by Executive Order
13563. Therefore, OMB reviewed this
final rule.
Regulatory Flexibility Act
We certify that this final rule would
not have a significant economic impact
on a substantial number of small entities
because they affect individuals only.
Therefore, a regulatory flexibility
analysis is not required under the
Regulatory Flexibility Act, as amended.
Paperwork Reduction Act
This final rule does not create any
new or affect any existing collections
and, therefore, does not require OMB
5 See
20 CFR 416.924a and 416.926a.
U.S.C. 405(a), 902(a)(5), and 1383(d)(1).
7 This means that we will use this final rule on
and after its effective date in any case in which we
make a determination or decision. We expect that
Federal courts will review our final decisions using
the rule that was in effect at the time we issued the
decisions. If a court reverses our final decision and
remands a case for further administrative
proceedings after the effective date of this final rule,
we will apply this final rule to the entire period at
issue in the decision we make after the court’s
remand.
wreier-aviles on DSK5TPTVN1PROD with RULES
6 42
VerDate Sep<11>2014
15:35 Apr 10, 2015
Jkt 235001
List of Subjects
20 CFR Part 404
19525
n. Redesignate section 106.00C5 of
part B as 106.00C6 and add new section
106.00C5.
■ o. Add listing 106.08 of part B.
■ p. Add section 114.00F4d of part B.
■ q. Revise listing 114.08H of part B.
The revisions and additions read as
follows:
■
APPENDIX 1 TO SUBPART P OF PART
404—LISTING OF IMPAIRMENTS
Administrative practice and
procedure; Blind, Disability benefits;
Old-Age, Survivors, and Disability
Insurance; Reporting and recordkeeping
requirements; Social Security.
1. Low Birth Weight and Failure to Thrive
(100.00): June 12, 2020.
20 CFR Part 416
*
Administrative practice and
procedure; Aged, Blind, Disability
benefits; Public assistance programs;
Reporting and recordkeeping
requirements; Supplemental Security
Income (SSI).
100.00 Low Birth Weight and Failure to
Thrive.
Carolyn W. Colvin,
Acting Commissioner of Social Security.
For the reasons set out in the
preamble, we are amending 20 CFR part
404 subpart P and part 416 subpart I as
set forth below:
PART 404—FEDERAL OLD-AGE,
SURVIVORS AND DISABILITY
INSURANCE (1950–)
1. The authority citation for subpart P
of part 404 continues to read as follows:
■
Authority: Secs. 202, 205(a)–(b) and (d)–
(h), 216(i), 221(a), (i), and (j), 222(c), 223,
225, and 702(a)(5) of the Social Security Act
(42 U.S.C. 402, 405(a)–(b) and (d)–(h), 416(i),
421(a), (i), and (j), 422(c), 423, 425, and
902(a)(5)); sec. 211(b), Pub. L. 104–193, 110
Stat. 2105, 2189; sec. 202, Pub. L. 108–203,
118 Stat. 509 (42 U.S.C. 902 note).
2. Amend appendix 1 to subpart P of
part 404 as follows:
■ a. Revise item 1 of the introductory
text before part A of appendix 1.
■ b. Amend part B by revising the body
system name for section 100.00 in the
table of contents.
■ c. Revise sections 100.00 and 100.01
of part B.
■ d. Remove sections 100.02 and 100.03
of part B.
■ e. Add sections 100.04 and 100.05 of
part B
■ f. Add section 103.00F of part B.
■ g. Add listing 103.06 of part B.
■ h. Revise section 104.00C2b
introductory text of part B.
■ i. Revise section 104.00C2b(ii) of part
B.
■ j. Add section 104.00C3 of part B.
■ k. Revise listing 104.02C of part B.
■ l. Revise section 105.00G of part B.
■ m. Revise listing 105.08 of part B.
■
PO 00000
Frm 00015
Fmt 4700
Sfmt 4700
*
*
*
*
*
*
*
*
*
*
*
*
*
Part B
*
*
*
*
*
*
100.00 LOW BIRTH WEIGHT AND
FAILURE TO THRIVE
A. What conditions do we evaluate under
these listings? We evaluate low birth weight
(LBW) in infants from birth to attainment of
age 1 and failure to thrive (FTT) in infants
and toddlers from birth to attainment of age
3.
B. How do we evaluate disability based on
LBW under 100.04? In 100.04A and 100.04B,
we use an infant’s birth weight as
documented by an original or certified copy
of the infant’s birth certificate or by a medical
record signed by a physician. Birth weight
means the first weight recorded after birth. In
100.04B, gestational age is the infant’s age
based on the date of conception as recorded
in the medical record. If the infant’s
impairment meets the requirements for
listing 100.04A or 100.04B, we will follow
the rule in § 416.990(b)(11) of this chapter.
C. How do we evaluate disability based on
FTT under 100.05?
1. General. We establish FTT with or
without a known cause when we have
documentation of an infant’s or a toddler’s
growth failure and developmental delay from
an acceptable medical source(s) as defined in
§ 416.913(a) of this chapter. We require
documentation of growth measurements in
100.05A and developmental delay described
in 100.05B or 100.05C within the same
consecutive 12-month period. The dates of
developmental testing and reports may be
different from the dates of growth
measurements. After the attainment of age 3,
we evaluate growth failure under the affected
body system(s).
2. Growth failure. Under 100.05A, we use
the appropriate table(s) under 105.08B in the
digestive system to determine whether a
child’s growth is less than the third
percentile. The child does not need to have
a digestive disorder for purposes of 100.05.
a. For children from birth to attainment of
age 2, we use the weight-for-length table
corresponding to the child’s gender (Table I
or Table II).
b. For children age 2 to attainment of age
3, we use the body mass index (BMI)-for-age
table corresponding to the child’s gender
(Table III or Table IV).
E:\FR\FM\13APR1.SGM
13APR1
wreier-aviles on DSK5TPTVN1PROD with RULES
19526
Federal Register / Vol. 80, No. 70 / Monday, April 13, 2015 / Rules and Regulations
c. BMI is the ratio of a child’s weight to the
square of his or her height. We calculate BMI
using the formulas in 105.00G2c.
d. Growth measurements. The weight-forlength measurements for children from birth
to the attainment of age 2 and BMI-for-age
measurements for children age 2 to
attainment of age 3 that are required for this
listing must be obtained within a 12-month
period and at least 60 days apart. If a child
attains age 2 during the evaluation period,
additional measurements are not needed.
Any measurements taken before the child
attains age 2 can be used to evaluate the
impairment under the appropriate listing for
the child’s age. If the child attains age 3
during the evaluation period, the
measurements can be used to evaluate the
impairment in the affected body system.
3. Developmental delay.
a. Under 100.05B and C, we use reports
from acceptable medical sources to establish
delay in a child’s development.
b. Under 100.05B, we document the
severity of developmental delay with results
from a standardized developmental
assessment, which compares a child’s level
of development to the level typically
expected for his or her chronological age. If
the child was born prematurely, we may use
the corrected chronological age (CCA) for
comparison. (See § 416.924b(b) of this
chapter.) CCA is the chronological age
adjusted by a period of gestational
prematurity. CCA = (chronological age)—
(number of weeks premature). Acceptable
medical sources or early intervention
specialists, physical or occupational
therapists, and other sources may conduct
standardized developmental assessments and
developmental screenings. The results of
these tests and screenings must be
accompanied by a statement or records from
an acceptable medical source who
established the child has a developmental
delay.
c. Under 100.05C, when there are no
results from a standardized developmental
assessment in the case record, we need
narrative developmental reports from the
child’s medical sources in sufficient detail to
assess the severity of his or her
developmental delay. A narrative
developmental report is based on clinical
observations, progress notes, and well-baby
check-ups. To meet the requirements for
100.05C, the report must include: The child’s
developmental history; examination findings
(with abnormal findings noted on repeated
examinations); and an overall assessment of
the child’s development (that is, more than
one or two isolated skills) by the medical
source. Some narrative developmental
reports may include results from
developmental screening tests, which can
identify a child who is not developing or
achieving skills within expected timeframes.
Although medical sources may refer to
screening test results as supporting evidence
in the narrative developmental report,
screening test results alone cannot establish
a diagnosis or the severity of developmental
delay.
D. How do we evaluate disorders that do
not meet one of these listings?
1. We may find infants disabled due to
other disorders when their birth weights are
VerDate Sep<11>2014
15:35 Apr 10, 2015
Jkt 235001
greater than 1200 grams but less than 2000
grams and their weight and gestational age do
not meet listing 100.04. The most common
disorders of prematurity and LBW include
retinopathy of prematurity (ROP), chronic
lung disease of infancy (CLD, previously
known as bronchopulmonary dysplasia, or
BPD), intraventricular hemorrhage (IVH),
necrotizing enterocolitis (NEC), and
periventricular leukomalacia (PVL). Other
disorders include poor nutrition and growth
failure, hearing disorders, seizure disorders,
cerebral palsy, and developmental disorders.
We evaluate these disorders under the
affected body systems.
2. We may evaluate infants and toddlers
with growth failure that is associated with a
known medical disorder under the body
system of that medical disorder, for example,
the respiratory or digestive body systems.
3. If an infant or toddler has a severe
medically determinable impairment(s) that
does not meet the criteria of any listing, we
must also consider whether the child has an
impairment(s) that medically equals a listing
(see § 416.926 of this chapter). If the child’s
impairment(s) does not meet or medically
equal a listing, we will determine whether
the child’s impairment(s) functionally equals
the listings (see § 416.926a of this chapter)
considering the factors in § 416.924a of this
chapter. We use the rule in § 416.994a of this
chapter when we decide whether a child
continues to be disabled.
100.01 Category of Impairments, Low Birth
Weight and Failure to Thrive
100.04 Low birth weight in infants from
birth to attainment of age 1.
A. Birth weight (see 100.00B) of less than
1200 grams.
OR
B. The following gestational age and birth
weight:
Gestational
age
(in weeks)
37–40 ..........
36 ................
35 ................
34 ................
33 ................
32 ................
Birth weight
2000
1875
1700
1500
1325
1250
grams
grams
grams
grams
grams
grams
or
or
or
or
or
or
less.
less.
less.
less.
less.
less.
100.05 Failure to thrive in children from
birth to attainment of age 3 (see 100.00C),
documented by A and B, or A and C.
A. Growth failure as required in 1 or 2:
1. For children from birth to attainment of
age 2, three weight-for-length measurements
that are:
a. Within a consecutive 12-month period;
and
b. At least 60 days apart; and
c. Less than the third percentile on the
appropriate weight-for-length table in listing
105.08B1; or
2. For children age 2 to attainment of age
3, three BMI-for-age measurements that are:
a. Within a consecutive 12-month period;
and
b. At least 60 days apart; and
c. Less than the third percentile on the
appropriate BMI-for-age table in listing
105.08B2.
PO 00000
Frm 00016
Fmt 4700
Sfmt 4700
AND
B. Developmental delay (see 100.00C1 and
C3), established by an acceptable medical
source and documented by findings from one
current report of a standardized
developmental assessment (see 100.00C3b)
that:
1. Shows development not more than twothirds of the level typically expected for the
child’s age; or
2. Results in a valid score that is at least
two standard deviations below the mean.
OR
C. Developmental delay (see 100.00C3),
established by an acceptable medical source
and documented by findings from two
narrative developmental reports (see
100.00C3c) that:
1. Are dated at least 120 days apart (see
100.00C1); and
2. Indicate current development not more
than two-thirds of the level typically
expected for the child’s age.
*
*
103.00
*
*
*
*
RESPIRATORY SYSTEM
*
*
*
*
F. How do we evaluate growth failure due
to any chronic respiratory disorder?
1. To evaluate growth failure due to any
chronic respiratory disorder, we require
documentation of the oxygen
supplementation described in 103.06A and
the growth measurements in 103.06B within
the same consecutive 12-month period. The
dates of oxygen supplementation may be
different from the dates of growth
measurements.
2. Under 103.06B, we use the appropriate
table(s) under 105.08B in the digestive
system to determine whether a child’s growth
is less than the third percentile.
a. For children from birth to attainment of
age 2, we use the weight-for-length table
corresponding to the child’s gender (Table I
or Table II).
b. For children age 2 to attainment of age
18, we use the body mass index (BMI)-for-age
table corresponding to the child’s gender
(Table III or Table IV).
c. BMI is the ratio of a child’s weight to the
square of his or her height. We calculate BMI
using the formulas in 105.00G2c.
*
*
*
*
*
103.06 Growth failure due to any chronic
respiratory disorder (see 103.00F),
documented by:
A. Hypoxemia with the need for at least 1.0
L/min of oxygen supplementation for at least
4 hours per day and for at least 90
consecutive days.
AND
B. Growth failure as required in 1 or 2:
1. For children from birth to attainment of
age 2, three weight-for-length measurements
that are:
a. Within a consecutive 12-month period;
and
b. At least 60 days apart; and
c. Less than the third percentile on the
appropriate weight-for-length table under
105.08B1; or
2. For children age 2 to attainment of age
18, three BMI-for-age measurements that are:
E:\FR\FM\13APR1.SGM
13APR1
Federal Register / Vol. 80, No. 70 / Monday, April 13, 2015 / Rules and Regulations
a. Within a consecutive 12-month period;
and
b. At least 60 days apart; and
c. Less than the third percentile on the
appropriate BMI-for-age table under
105.08B2.
*
*
104.00
*
*
*
*
*
CARDIOVASCULAR SYSTEM
*
*
*
C. Evaluating Chronic Heart Failure
*
*
*
*
*
*
2. What evidence of CHF do we need?
*
*
*
*
*
*
*
*
*
(ii) During infancy, other manifestations of
chronic heart failure may include repeated
lower respiratory tract infections.
*
*
*
*
*
*
*
*
*
*
104.02 * * *
b. To establish that you have chronic heart
failure, we require that your medical history
and physical examination describe
characteristic symptoms and signs of
pulmonary or systemic congestion or of
limited cardiac output associated with
abnormal findings on appropriate medically
acceptable imaging. When a remediable
factor, such as arrhythmia, triggers an acute
episode of heart failure, you may experience
restored cardiac function, and a chronic
impairment may not be present.
*
(i) For children from birth to attainment of
age 2, we use the weight-for-length table
corresponding to the child’s gender (Table I
or Table II).
(ii) For children age 2 to attainment of age
18, we use the body mass index (BMI)-for-age
table corresponding to the child’s gender
(Table III or Table IV).
(iii) BMI is the ratio of a child’s weight to
the square of his or her height. We calculate
BMI using the formulas in 105.00G2c.
*
3. How do we evaluate growth failure due
to CHF?
a. To evaluate growth failure due to CHF,
we require documentation of the clinical
findings of CHF described in 104.00C2 and
the growth measurements in 104.02C within
the same consecutive 12-month period. The
dates of clinical findings may be different
from the dates of growth measurements.
b. Under 104.02C, we use the appropriate
table(s) under 105.08B in the digestive
system to determine whether a child’s growth
is less than the third percentile.
*
*
*
C. Growth failure as required in 1 or 2:
1. For children from birth to attainment of
age 2, three weight-for-length measurements
that are:
a. Within a consecutive 12-month period;
and
b. At least 60 days apart; and
c. Less than the third percentile on the
appropriate weight-for-length table under
105.08B1; or
2. For children age 2 to attainment of age
18, three BMI-for-age measurements that are:
a. Within a consecutive 12-month period;
and
b. At least 60 days apart; and
c. Less than the third percentile on the
appropriate BMI-for-age table under
105.08B2.
*
*
105.00
*
*
*
*
*
DIGESTIVE SYSTEM
*
*
*
G. How do we evaluate growth failure due
to any digestive disorder?
1. To evaluate growth failure due to any
digestive disorder, we require documentation
of the laboratory findings of chronic
nutritional deficiency described in 105.08A
and the growth measurements in 105.08B
within the same consecutive 12-month
period. The dates of laboratory findings may
19527
be different from the dates of growth
measurements.
2. Under 105.08B, we evaluate a child’s
growth failure by using the appropriate table
for age and gender.
a. For children from birth to attainment of
age 2, we use the weight-for-length table (see
Table I or Table II).
b. For children age 2 to attainment of age
18, we use the body mass index (BMI)-for-age
table (see Tables III or IV).
c. BMI is the ratio of a child’s weight to the
square of the child’s height. We calculate
BMI using one of the following formulas:
English Formula
BMI = [Weight in Pounds/(Height in Inches
× Height in Inches)] × 703
Metric Formulas
BMI = Weight in Kilograms/(Height in
Meters × Height in Meters)
BMI = [Weight in Kilograms/(Height in
Centimeters × Height in Centimeters)] ×
10,000
*
*
*
*
*
105.08 Growth failure due to any
digestive disorder (see 105.00G), documented
by A and B:
A. Chronic nutritional deficiency present
on at least two evaluations at least 60 days
apart within a consecutive 12-month period
documented by one of the following:
1. Anemia with hemoglobin less than 10.0
g/dL; or
2. Serum albumin of 3.0 g/dL or less;
AND
B. Growth failure as required in 1 or 2:
1. For children from birth to attainment of
age 2, three weight-for-length measurements
that are:
a. Within a 12-month period; and
b. At least 60 days apart; and
c. Less than the third percentile on Table
I or Table II; or
TABLE I—MALES BIRTH TO ATTAINMENT OF AGE 2
[Third Percentile Values for Weight-for-Length]
wreier-aviles on DSK5TPTVN1PROD with RULES
Length
(centimeters)
45.0
45.5
46.5
47.5
48.5
49.5
50.5
51.5
52.5
53.5
54.5
55.5
56.5
57.5
58.5
59.5
60.5
61.5
62.5
63.5
Weight
(kilograms)
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
VerDate Sep<11>2014
15:35 Apr 10, 2015
Jkt 235001
PO 00000
Length
(centimeters)
1.597
1.703
1.919
2.139
2.364
2.592
2.824
3.058
3.294
3.532
3.771
4.010
4.250
4.489
4.728
4.966
5.203
5.438
5.671
5.903
Frm 00017
Fmt 4700
Weight
(kilograms)
64.5
65.5
66.5
67.5
68.5
69.5
70.5
71.5
72.5
73.5
74.5
75.5
76.5
77.5
78.5
79.5
80.5
81.5
82.5
83.5
Sfmt 4700
Length
(centimeters)
6.132
6.359
6.584
6.807
7.027
7.245
7.461
7.674
7.885
8.094
8.301
8.507
8.710
8.913
9.113
9.313
9.512
9.710
9.907
10.104
E:\FR\FM\13APR1.SGM
13APR1
84.5
85.5
86.5
87.5
88.5
89.5
90.5
91.5
92.5
93.5
94.5
95.5
96.5
97.5
98.5
99.5
100.5
101.5
102.5
103.5
Weight
(kilograms)
10.301
10.499
10.696
10.895
11.095
11.296
11.498
11.703
11.910
12.119
12.331
12.546
12.764
12.987
13.213
13.443
13.678
13.918
14.163
14.413
19528
Federal Register / Vol. 80, No. 70 / Monday, April 13, 2015 / Rules and Regulations
TABLE II—FEMALES BIRTH TO ATTAINMENT OF AGE 2
[Third Percentile Values for Weight-for-Length]
Length
(centimeters)
45.0
45.5
46.5
47.5
48.5
49.5
50.5
51.5
52.5
53.5
54.5
55.5
56.5
57.5
58.5
59.5
60.5
61.5
62.5
63.5
Weight
(kilograms)
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
..................................................................
2. For children age 2 to attainment of age
18, three BMI-for-age measurements that are:
Length
(centimeters)
1.613
1.724
1.946
2.171
2.397
2.624
2.852
3.081
3.310
3.538
3.767
3.994
4.220
4.445
4.892
5.113
5.333
5.552
5.769
5.769
Weight
(kilograms)
64.5
65.5
66.5
67.5
68.5
69.5
70.5
71.5
72.5
73.5
74.5
75.5
76.5
77.5
78.5
79.5
80.5
81.5
82.5
83.5
Length
(centimeters)
5.985
6.200
6.413
6.625
6.836
7.046
7.254
7.461
7.667
7.871
8.075
8.277
8.479
8.679
8.879
9.078
9.277
9.476
9.674
9.872
a. Within a consecutive 12-month period;
and
b. At least 60 days apart; and
Weight
(kilograms)
84.5
85.5
86.5
87.5
88.5
89.5
90.5
91.5
92.5
93.5
94.5
95.5
96.5
97.5
98.5
99.5
100.5
101.5
102.5
103.5
10.071
10.270
10.469
10.670
10.871
11.074
11.278
11.484
11.691
11.901
12.112
12.326
12.541
12.760
12.981
13.205
13.431
13.661
13.895
14.132
c. Less than the third percentile on Table
III or Table IV.
TABLE III—MALES AGE 2 TO ATTAINMENT OF AGE 18
[Third Percentile Values for BMI-for-Age]
Age
(yrs. and
mos.)
Age
(yrs. and mos.)
BMI
2.0 to 2.1 ......
2.2 to 2.4 ......
2.5 to 2.7 ......
2.8 to 2.11 ....
3.0 to 3.2 ......
3.3 to 3.6 ......
3.7 to 3.11 ....
4.0 to 4.5 ......
4.6 to 5.0 ......
5.1 to 6.0 ......
6.1 to 7.6 ......
7.7 to 8.6 ......
8.7 to 9.1 ......
9.2 to 9.6 ......
9.7 to 9.11 ....
10.0 to 10.3 ..
10.4 to 10.7 ..
10.8 to 10.10
14.5
14.4
14.3
14.2
14.1
14.0
13.9
13.8
13.7
13.6
13.5
13.6
13.7
13.8
13.9
14.0
14.1
14.2
Age
(yrs. and mos.)
BMI
10.11 to 11.2
11.3 to 11.5
11.6 to 11.8
11.9 to 11.11
12.0 to 12.1
12.2 to 12.4
12.5 to 12.7
12.8 to 12.9
12.10 to 13.0
13.1 to 13.2
13.3 to 13.4
13.5 to 13.7
13.8 to 13.9
13.10 to 13.11
14.0 to 14.1
14.2 to 14.4
14.5 to 14.6
14.7 to 14.8
14.3
14.4
14.5
14.6
14.7
14.8
14.9
15.0
15.1
15.2
15.3
15.4
15.5
15.6
15.7
15.8
15.9
16.0
BMI
14.9 to 14.10
14.11 to 15.0
15.1 to 15.3
15.4 to 15.5
15.6 to 15.7
15.8 to 15.9
15.10 to 15.11
16.0 to 16.1
16.2 to 16.3
16.4 to 16.5
16.6 to 16.8
16.9 to 16.10
16.11 to 17.0
17.1 to 17.2
17.3 to 17.5
17.6 to 17.7
17.8 to 17.9
17.10 to 17.11
16.1
16.2
16.3
16.4
16.5
16.6
16.7
16.8
16.9
17.0
17.1
17.2
17.3
17.4
17.5
17.6
17.7
17.8
TABLE IV—FEMALES AGE 2 TO ATTAINMENT OF AGE 18
[Third Percentile Values for BMI-for-Age]
wreier-aviles on DSK5TPTVN1PROD with RULES
Age
(yrs. and mos.)
BMI
2.0 to 2.2 ..........................................................................................................
2.3 to 2.6 ..........................................................................................................
2.7 to 2.10 ........................................................................................................
2.11 to 3.2 ........................................................................................................
3.3 to 3.6 ..........................................................................................................
3.7 to 3.11 ........................................................................................................
4.0 to 4.4 ..........................................................................................................
4.5 to 4.11 ........................................................................................................
5.0 to 5.9 ..........................................................................................................
5.10 to 7.6 ........................................................................................................
VerDate Sep<11>2014
15:35 Apr 10, 2015
Jkt 235001
PO 00000
Frm 00018
Fmt 4700
14.1
14.0
13.9
13.8
13.7
13.6
13.5
13.4
13.3
13.2
Sfmt 4700
Age
(yrs. and mos.)
BMI
10.8 to 10.10
10.11 to 11.2
11.3 to 11.5
11.6 to 11.7
11.8 to 11.10
11.11 to 12.1
12.2 to 12.4
12.5 to 12.6
12.7 to 12.9
12.10 to 12.11
E:\FR\FM\13APR1.SGM
14.0
14.1
14.2
14.3
14.4
14.5
14.6
14.7
14.8
14.9
13APR1
Age
(yrs. and mos.)
14.3 to 14.5
14.6 to 14.7
14.8 to 14.9
14.10 to 15.0
15.1 to 15.2
15.3 to 15.5
15.6 to 15.7
15.8 to 15.10
15.11 to 16.0
16.1 to 16.3
BMI
15.6
15.7
15.8
15.9
16.0
16.1
16.2
16.3
16.4
16.5
Federal Register / Vol. 80, No. 70 / Monday, April 13, 2015 / Rules and Regulations
19529
TABLE IV—FEMALES AGE 2 TO ATTAINMENT OF AGE 18—Continued
[Third Percentile Values for BMI-for-Age]
Age
(yrs. and mos.)
BMI
7.7 to 8.4 ..........................................................................................................
8.5 to 8.10 ........................................................................................................
8.11 to 9.3 ........................................................................................................
9.4 to 9.8 ..........................................................................................................
9.9 to 10.0 ........................................................................................................
10.1 to 10.4 ......................................................................................................
10.5 to 10.7 ......................................................................................................
*
*
106.00
*
*
*
*
114.00
*
GENITOURINARY IMPAIRMENTS
*
*
*
C. What other factors do we consider when
we evaluate your genitourinary disorder?
*
*
*
*
*
5. Growth failure due to any chronic renal
disease.
a. To evaluate growth failure due to any
chronic renal disease, we require
documentation of the laboratory findings
described in 106.08A and the growth
measurements in 106.08B within the same
consecutive 12-month period. The dates of
laboratory findings may be different from the
dates of growth measurements.
b. Under 106.08B, we use the appropriate
table(s) under 105.08B in the digestive
system to determine whether a child’s growth
is less than the third percentile.
(i) For children from birth to attainment of
age 2, we use the weight-for-length table
corresponding to the child’s gender (Table I
or Table II).
(ii) For children age 2 to attainment of age
18, we use the body mass index (BMI)-for-age
table corresponding to the child’s gender
(Table III or Table IV).
(iii) BMI is the ratio of a child’s weight to
the square of his or her height. We calculate
BMI using the formulas in 105.00G2c.
wreier-aviles on DSK5TPTVN1PROD with RULES
*
*
*
*
*
106.08 Growth failure due to any chronic
renal disease (see 106.00C5), with:
A. Serum creatinine of 2 mg/dL or greater,
documented at least two times within a
consecutive 12-month period with at least 60
days between measurements.
AND
B. Growth failure as required in 1 or 2:
1. For children from birth to attainment of
age 2, three weight-for-length measurements
that are:
a. Within a consecutive 12-month period;
and
b. At least 60 days apart; and
c. Less than the third percentile on the
appropriate weight-for-length table under
105.08B1; or
2. For children age 2 to attainment of age
18, three BMI-for-age measurements that are:
a. Within a consecutive 12-month period;
and
b. At least 60 days apart; and
c. Less than the third percentile on the
appropriate BMI-for-age table under
105.08B2.
*
*
*
VerDate Sep<11>2014
*
*
15:35 Apr 10, 2015
Jkt 235001
*
Age
(yrs. and mos.)
13.3
13.4
13.5
13.6
13.7
13.8
13.9
13.0
13.3
13.5
13.8
13.10
14.1
IMMUNE SYSTEM DISORDERS
*
*
*
*
*
*
*
F. * * *
*
*
4. HIV infection manifestations specific to
children.
*
*
*
*
*
d. Growth failure due to HIV immune
suppression.
(i) To evaluate growth failure due to HIV
immune suppression, we require
documentation of the laboratory values
described in 114.08H1 and the growth
measurements in 114.08H2 or 114.08H3
within the same consecutive 12-month
period. The dates of laboratory findings may
be different from the dates of growth
measurements.
(ii) Under 114.08H2 and 114.08H3, we use
the appropriate table under 105.08B in the
digestive system to determine whether a
child’s growth is less than the third
percentile.
(A) For children from birth to attainment
of age 2, we use the weight-for-length table
corresponding to the child’s gender (Table I
or Table II).
(B) For children age 2 to attainment of age
18, we use the body mass index (BMI)-for-age
table corresponding to the child’s gender
(Table III or Table IV).
(C) BMI is the ratio of a child’s weight to
the square of his or her height. We calculate
BMI using the formulas in 105.00G2c.
*
*
*
*
*
*
*
114.08 * * *
*
*
*
H. Immune suppression and growth failure
(see 114.00F4d) documented by 1 and 2, or
by 1 and 3.
1. CD4 measurement:
a. For children from birth to attainment of
age 5, CD4 percentage of less than 20 percent;
or
b. For children age 5 to attainment of age
18, absolute CD4 count of less than 200 cells/
mm3, or CD4 percentage of less than 14
percent; and
2. For children from birth to attainment of
age 2, three weight-for-length measurements
that are:
a. Within a consecutive 12-month period;
and
b. At least 60 days apart; and
c. Less than the third percentile on the
appropriate weight-for-length table under
105.08B1; or
3. For children age 2 to attainment of age
18, three BMI-for-age measurements that are:
PO 00000
Frm 00019
Fmt 4700
Sfmt 4700
to
to
to
to
to
to
Age
(yrs. and mos.)
BMI
13.2
13.4
13.7
13.9
14.0
14.2
15.0
15.1
15.2
15.3
15.4
15.5
16.4 to 16.6
16.7 to 16.9
16.10 to 17.0
17.1 to 17.3
17.4 to 17.7
17.8 to 17.11
BMI
16.6
16.7
16.8
16.9
17.0
17.1
a. Within a consecutive 12-month period;
and
b. At least 60 days apart; and
c. Less than the third percentile on the
appropriate BMI-for-age table under
105.08B2.
*
*
*
*
*
PART 416—SUPPLEMENTAL
SECURITY INCOME FOR THE AGED,
BLIND, AND DISABLED
Subpart I—[Amended]
3. The authority citation for subpart I
of part 416 continues to read as follows:
■
Authority: Secs. 221(m), 702(a)(5), 1611,
1614, 1619, 1631(a), (c), (d)(1), and (p), and
1633 of the Social Security Act (42 U.S.C.
421(m), 902(a)(5), 1382, 1382c, 1382h,
1383(a), (c), (d)(1), and (p), and 1383b); secs.
4(c) and 5, 6(c)–(e), 14(a), and 15, Pub. L. 98–
460, 98 Stat. 1794, 1801, 1802, and 1808 (42
U.S.C. 421 note, 423 note, and 1382h note).
4. Amend § 416.924b by revising
paragraph (b) to read as follows:
■
§ 416.924b Age as a factor of evaluation in
the sequential evaluation process for
children.
*
*
*
*
*
(b) Correcting chronological age of
premature infants. We generally use
chronological age (a child’s age based on
birth date) when we decide whether, or
the extent to which, a physical or
mental impairment or combination of
impairments causes functional
limitations. However, if you were born
prematurely, we may consider you
younger than your chronological age
when we evaluate your development.
We may use a ‘‘corrected’’ chronological
age (CCA); that is, your chronological
age adjusted by a period of gestational
prematurity. We consider an infant born
at less than 37 weeks’ gestation to be
born prematurely.
(1) We compute your CCA by
subtracting the number of weeks of
prematurity (the difference between 40
weeks of full-term gestation and the
number of actual weeks of gestation)
from your chronological age. For
example, if your chronological age is 20
E:\FR\FM\13APR1.SGM
13APR1
19530
Federal Register / Vol. 80, No. 70 / Monday, April 13, 2015 / Rules and Regulations
weeks but you were born at 32 weeks
gestation (8 weeks premature), then
your CCA is 12 weeks.
(2) We evaluate developmental delay
in a premature child until the child’s
prematurity is no longer a relevant
factor, generally no later than about
chronological age 2.
(i) If you have not attained age 1 and
were born prematurely, we will assess
your development using your CCA.
(ii) If you are over age 1 and have a
developmental delay, and prematurity is
still a relevant factor, we will decide
whether to correct your chronological
age. We will base our decision on our
judgment and all the facts in your case.
If we decide to correct your
chronological age, we may correct it by
subtracting the full number of weeks of
prematurity or a lesser number of
weeks. If your developmental delay is
the result of your medically
determinable impairment(s) and is not
attributable to your prematurity, we will
decide not to correct your chronological
age.
(3) Notwithstanding the provisions in
paragraph (b)(1) of this section, we will
not compute a CCA if the medical
evidence shows that your treating
source or other medical source has
already taken your prematurity into
consideration in his or her assessment
of your development. We will not
compute a CCA when we find you
disabled under listing 100.04 of the
Listing of Impairments.
§ 416.926a
[Amended]
5. Amend § 416.926a by removing
paragraphs (m)(6) and (m)(7) and
redesignating paragraph (m)(8) as (m)(6).
■
6. Amend § 416.934 by adding
paragraphs (j) and (k) to read as follows:
■
§ 416.934 Impairments which may warrant
a finding of presumptive disability or
presumptive blindness.
wreier-aviles on DSK5TPTVN1PROD with RULES
*
*
*
*
*
(j) Infants weighing less than 1200
grams at birth, until attainment of 1 year
of age.
(k) Infants weighing at least 1200 but
less than 2000 grams at birth, and who
are small for gestational age, until
attainment of 1 year of age. (Small for
gestational age means a birth weight that
is at or more than 2 standard deviations
below the mean or that is less than the
third growth percentile for the
gestational age of the infant.)
[FR Doc. 2015–08185 Filed 4–10–15; 8:45 am]
BILLING CODE 4191–02–P
VerDate Sep<11>2014
15:35 Apr 10, 2015
Jkt 235001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Part 1020
[Docket No. FDA–2015–N–0828]
Performance Standards for Ionizing
Radiation Emitting Products;
Fluoroscopic Equipment; Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Direct final rule.
The Food and Drug
Administration (FDA) is amending a
Federal performance standard for
ionizing radiation to correct a drafting
error regarding fluoroscopic equipment
measurement. We are taking this action
to ensure clarity and improve the
accuracy of the regulations.
DATES: This rule is effective August 26,
2015. Submit electronic or written
comments on this direct final rule or its
companion proposed rule by June 29,
2015.
SUMMARY:
You may submit comments
by any of the following methods:
ADDRESSES:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Written Submissions
Submit written comments in the
following ways:
• Mail/Hand delivery/Courier (for
paper submissions): Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852.
Instructions: All submissions received
must include the Docket No. FDA–
2015–N–0828 for this rulemaking. All
comments received may be posted
without change to https://
www.regulations.gov, including any
personal information provided. For
additional information on submitting
comments, see the ‘‘Comments’’ heading
of the SUPPLEMENTARY INFORMATION
section of this document.
Docket: For access to the docket to
read background documents or
comments received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Division of Dockets
Management, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852.
PO 00000
Frm 00020
Fmt 4700
Sfmt 4700
FOR FURTHER INFORMATION CONTACT:
Scott Gonzalez, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 4641, Silver Spring,
MD 20993–0002, 301–796–5889.
SUPPLEMENTARY INFORMATION:
I. What is the background of this Rule?
FDA is correcting a drafting error
regarding fluoroscopic equipment
measurement in § 1020.32 (21 CFR
1020.32). We are publishing this direct
final rule because it is intended to make
a noncontroversial amendment to
§ 1020.32, and we do not anticipate any
significant adverse comments.
Specifically, this amendment changes
the words ‘‘any linear dimension’’ in the
current regulation to read ‘‘every linear
dimension’’ (§ 1020.32(b)(4)(ii)(A)). The
alternative performance standard,
§ 1020.32(b)(4)(ii)(B), currently contains
the same phrase but remains
unchanged. We are amending the
language to make the performance
standards mutually exclusive. This will
ensure clarity and improve the accuracy
of the regulations.
FDA first proposed the performance
standards in the Federal Register of
December 10, 2002 (67 FR 76056), to
account for technological changes in
fluoroscopic equipment. The proposed
rule did not specify which measurement
of the visible area of an image receptor
determined the applicable performance
standard (67 FR 76056 at 76092). When
we addressed comments to the proposed
rule in the Federal Register of June 10,
2005, we agreed with one comment that
adding the words ‘‘any linear
dimension’’ would clarify the
determination of the performance
standard (70 FR 33998 at 34007).
FDA ultimately incorporated the
phrase in two places, potentially
reducing the clarity of the rule (70 FR
33998 at 34040). Section
1020.32(b)(4)(ii) sets performance
standards based on a threshold, so the
language for each standard should be
mutually exclusive. That is, only one
standard, and not the other, should
apply to the image receptor in question.
However, some image receptors may
have linear dimensions that are both
greater than and less than 34 cm, for
example, receptors with a hexagonal
shape. In such cases, the performance
standards may not be mutually
exclusive, so both standards may appear
to apply. This direct final rule amends
§ 1020.32(b)(4)(ii)(A) to read ‘‘every
linear dimension’’ to ensure the
standards are mutually exclusive. The
amendment will improve the clarity and
accuracy of the regulations.
E:\FR\FM\13APR1.SGM
13APR1
Agencies
[Federal Register Volume 80, Number 70 (Monday, April 13, 2015)]
[Rules and Regulations]
[Pages 19522-19530]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-08185]
=======================================================================
-----------------------------------------------------------------------
SOCIAL SECURITY ADMINISTRATION
20 CFR Parts 404 and 416
[Docket No. SSA-2011-0081]
RIN 0960-AG28
Revised Listings for Growth Disorders and Weight Loss in Children
AGENCY: Social Security Administration.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This rule adopts, with one change, the rule for evaluating
growth disorders in children we proposed in a notice of proposed
rulemaking (NPRM) published in the Federal Register on May 22, 2013.
Several body systems in the Listing of Impairments (listings) contain
listings for children based on impairment of linear growth or weight
loss. We are replacing those listings with new listings for low birth
weight (LBW) and failure to thrive; a new listing for genitourinary
impairments; and revised listings for growth failure in combination
with a respiratory, cardiovascular, digestive, or immune system
disorder. These revisions reflect our program experience, advances in
medical knowledge, and comments we received from medical experts and
the public.
DATES: This rule is effective June 12, 2015.
[[Page 19523]]
FOR FURTHER INFORMATION CONTACT: Cheryl A. Williams, Office of Medical
Policy, Social Security Administration, 6401 Security Boulevard,
Baltimore, Maryland 21235-6401, (410) 965-1020. For information on
eligibility or filing for benefits, call our national toll-free number,
1-800-772-1213, or TTY 1-800-325-0778, or visit our Internet site,
Social Security Online, at https://www.socialsecurity.gov.
SUPPLEMENTARY INFORMATION:
Background
We are adopting, as final, the rule for evaluating growth disorders
in children we proposed in an NPRM published in the Federal Register on
May 22, 2013 at 78 FR 30249. We made one addition to this rule as the
result of a public comment suggesting we provide guidance for
evaluating LBW in children born at less than 32 weeks gestation or
weighing less than 1325 grams. We revised the table in listing 100.04B
to include 32 weeks in the Gestational Age column because we believe
that this guidance is appropriate.
The preamble to the NPRM discussed the remaining changes from our
current rule and our reasons for proposing those changes. To the extent
that we are adopting the proposed rule as published, we are not
repeating that information here. Interested readers may refer to the
preamble to the NPRM, available at https://www.regulations.gov under
docket number SSA-2011-0081.
Why are we revising the listings for evaluating growth disorders in
children?
We are revising the listings for evaluating growth disorders in
children to update the medical criteria, provide more information on
how we evaluate growth disorders, reflect our program experience, and
address adjudicator questions.
Public Comments on the NPRM
In the NPRM, we provided the public with a 60-day comment period,
which ended on July 22, 2013. We received six comments. The commenters
included state agencies that make disability determinations for us, the
National Association of Disability Examiners, medical organizations,
such as the American Academy of Pediatrics, and advocacy groups, such
as the Endocrine Society. We carefully considered all of the comments,
summarized the commenters' views, and responded to all of the
significant issues that were within the scope of this rule. Some
commenters noted provisions with which they agreed and did not make
suggestions for changes in those provisions. We did not summarize or
respond to those comments.
Listing 100.04 Low Birth Weight in Infants From Birth to Attainment of
Age 1
Low Birth Weight
Comment: One commenter suggested that we provide guidance in the
listings at 100.04A or 100.04B, or in the introductory text at 100.00,
on diaries used to schedule continuing disability reviews (CDR) for LBW
infants. The commenter believes that, while this guidance is already in
our internal operating instructions, providing it in the regulations
would reduce the number of incorrect diaries being set for LBW cases.
Response: We did not adopt this comment. In 100.00B, we include a
reference to our rule for CDRs for LBW cases at Sec. 416.990(b)(11).
Additionally, the Act requires, with one exception, that we perform a
CDR not later than 12 months after the birth of an infant whose LBW is
a contributing factor material to the determination that the infant is
disabled. We will continue to provide guidance on diaries for LBW cases
and cases involving other disabling impairments in our internal
operating instructions. We do not believe it is necessary to repeat
this guidance in the regulation.
Comment: One commenter expressed concern that listing 100.04
suggests that LBW is a disability. The commenter felt that it should be
clear that weight is ``a proxy measure for prematurity, dysphagia, and
other functional impairments that are associated with disabilities,
rather than weight as a disability itself.'' The commenter did not
provide suggested language to include in our rule.
Response: We did not adopt this comment. We agree that, for the
purposes of listing 100.04, weight is a proxy measure for disability in
infants from birth to the attainment of age 1. However, we do not
believe that providing additional guidance is necessary for the clarity
of our rule. As we noted in the preamble to the proposed rule, we based
listing 100.04 on sections 416.926a(m)(6) and (m)(7) of our functional
equivalence rule.\1\ Our adjudicators have over 20 years of experience
evaluating claims filed on behalf of children based on LBW under our
functional equivalence rule. In our experience applying this rule, we
have not found that the type of guidance the commenter suggested is
necessary in order to apply the rule properly.
---------------------------------------------------------------------------
\1\ 78 FR at 30350.
---------------------------------------------------------------------------
Evaluating Infants Born at 33 Weeks Weighing Less Than 1325 Grams
Comment: One commenter suggested that we add guidance for
evaluating infants who weigh between 1200 grams and 1325 grams, and who
are born at gestational ages of 32 weeks or less.
Response: We partially adopted this comment. We agree that it is
appropriate to provide guidance for evaluating LBW in infants who are
born at 32 weeks gestational age. We revised the table in 100.04B to
provide a birth weight value of 1250 grams or less for the gestational
age of 32 weeks. However, we did not provide birth weight values for
gestational ages less than 32 weeks. The birth weight values that we
would provide for infants born at less than 32 weeks would be less than
1200 grams and, thus, the birth weight would meet the criterion in
100.04A.
Listing 100.05 Failure To Thrive in Children From Birth to Attainment
of Age 3
Growth Measurements
Comment: One commenter recommended including growth curves in
100.05A to make administrative processing for pediatricians easier.
Another commenter suggested that we make determinations based on growth
measurements alone without requiring a diagnosis of developmental
delay.
Response: We did not adopt these comments. In 100.05A, we require
three weight-for-length measurements or body mass index (BMI)-for-age
measurements that are within a 12-month period, at least 60-days apart,
and less than the third percentile on the appropriate table in listing
105.08B.2. The adjudicator making the disability determination uses the
information from growth curves provided by the child's pediatrician to
find the corresponding values on the tables provided. We do not believe
it is necessary to include the growth curves in the listing because our
adjudicators use the listing, rather than the pediatrician who
evaluates a child.
As we stated in the NPRM, our program experience has shown that
growth failure alone is not disabling (78 FR at 30251). To meet the
severity requirements for listing 100.05B, the child must have growth
failure with a developmental delay of the appropriate severity required
by the listing. Children with growth failure without developmental
delay may be evaluated in the appropriate body system of the underlying
condition causing the growth failure.
[[Page 19524]]
Developmental Testing
Comment: One commenter questioned the requirement for two narrative
developmental reports in 100.05C and the requirement that these two
reports be at least 120 days apart. This commenter suggested that, if
we keep the requirement for two reports, we should require a shorter
period of either 30 or 60 days between them. Another commenter also
expressed concern about the requirements for the evidence of
developmental delay. This commenter was concerned about the
availability of these records from providers.
Response: We did not adopt these comments. In 100.05C, we require
two narrative developmental reports when a report of a standardized
developmental assessment required by 100.05B is not available. As we
explained in the NPRM, abnormal findings noted on repeated
examinations, and information in narrative developmental reports, that
may include the results of developmental screening tests, can identify
a child who is not developing or achieving skills within expected
timeframes.\2\
---------------------------------------------------------------------------
\2\ 78 FR at 30251.
---------------------------------------------------------------------------
We do not believe that 30 or 60 days is enough time for these kinds
of changes to appear on testing. We believe that 120 days is an
appropriate period for developmental testing to be performed and to
allow for any changes in development to show on testing.
While we understand the commenter's concern about the availability
of evidence, we believe that, for the children whose impairments we
evaluate under listing 100.05, evidence generally will be available
from providers because these children are likely to be identified, and
subsequently treated because of their identification, by early
intervention programs.
Comment: One commenter noted that most early intervention programs
use ``a 25 percent delay criteria as opposed to the two-thirds
criteria'' required in 100.05C. However, the commenter did not provide
any suggestions for changing the criterion.
Response: We did not adopt this comment. We recognize that early
intervention programs often use a 25 percent delay criterion to
determine eligibility for intervention services and to identify the
needed services. In contrast, we evaluate a child's delay to determine
whether the underlying impairment is disabling because it results in
``marked and severe functional limitations.'' An impairment results in
``marked and severe functional limitations'' only if it meets,
medically equals, or functionally equals the listings. An impairment is
of listing-level severity if it results in ``marked'' limitations in
two domains of functioning or an ``extreme'' limitation in one
domain.\3\ The level of delay that we require in 100.05C is consistent
with our definition of ``marked limitation'' in Sec.
416.926a(e)(2)(ii).
---------------------------------------------------------------------------
\3\ See 20 CFR 416.926a(a).
---------------------------------------------------------------------------
Comment: One commenter expressed concern about acceptable
timeframes for performing developmental testing in relation to
disability determinations stated in 100.05B and 100.05C. The commenter
suggested that the testing to establish the child's current level of
development be performed within 6 months of adjudication.
Response: We partially adopted this comment. We agree that evidence
about a child's development must be recent and current in relation to a
disability determination, and we have revised listings 100.05B and
100.05C2 to clarify this requirement. However, the facts in a specific
case determine whether the evidence is current. Determining factors
include, but are not limited to, the age of the child, the amount of
delay, and the developmental trajectory documented over time. We are
not setting specific timeframes for when developmental testing must be
performed, but we are specifying that the evidence must reflect the
child's current development.
Linear Growth
Comment: One commenter agreed with our use of weight-for-length and
BMI-for-age charts to evaluate growth failure, rather than of linear
(height or length) growth charts. The commenter expressed concern,
however, that an underlying condition could cause a child to have such
profound growth failure that BMI for the child's age would become
normal, despite his or her significant growth failure.
Response: We did not adopt this comment. We understand the
commenter's concerns that some children may have underlying conditions
that cause linear growth impairments while their BMI-for-age
measurements are normal. After attainment of age 2, most children
without an underlying medical disorder follow a growth trajectory that
remains fairly constant during childhood.
Our adjudicative experience has shown that a declining linear
growth rate is not always indicative of a disabling condition. Short
stature, length, or height below the third percentile, in and of
itself, is not a medically determinable impairment, although it can be
the result of a medically determinable impairment. We will evaluate
children with growth failure that does not meet the requirements of
listings 100.04 and 100.05 and is associated with a known medically
determinable impairment under the affected body system.
Comment: One commenter was concerned that, while the majority of
children over the age of 3 with growth failure have signs and symptoms
of an underlying disorder in the respiratory, cardiovascular,
digestive, genitourinary, or immune body system, some children over the
age of 3 will not. This commenter suggested that we include exceptions
for conditions, such as Turner syndrome (female hypogonadism) and
acquired growth hormone deficiency, where growth failure may be a
significant component of the disease process.
Response: We did not adopt this comment. After a child attains age
3, we will evaluate his or her impairment under the affected body
system. The two examples provided by the commenter are endocrine
disorders. Although these two disorders are not listed impairments for
children, they may rise to listing-level severity because of their
effects in other body systems. As the commenter explained, children
with Turner syndrome may experience complications, such as heart
disease, to a degree that is disabling. We would evaluate the
complications under the affected body system.
Listing 103.06 Growth Failure Due to Any Chronic Respiratory Disorder
Comment: Two commenters were concerned with the requirement for
oxygen supplementation in 103.06A. The commenters noted that some
respiratory disorders, such as asthma, bronchiectasis, and cystic
fibrosis, could result in listing-level growth failure without
requiring oxygen supplementation.
Response: We did not adopt these comments. We agree with the
commenters that some respiratory disorders could result in listing-
level growth failure without requiring oxygen supplementation; however,
we did not revise 103.06 as a result. We use other listings, such as
103.02, 103.03, and 103.04, in the respiratory body system to evaluate
these disorders.\4\ We believe that these respiratory listings, and our
functional equivalence rule for evaluating disability in children,
[[Page 19525]]
adequately address the disorders referred to by the commenters.\5\
---------------------------------------------------------------------------
\4\ See 20 CFR part 404, subpart P, Appendix 1.
\5\ See 20 CFR 416.924a and 416.926a.
---------------------------------------------------------------------------
What is our authority to make rules and set procedures for determining
whether a person is disabled under the statutory definition?
The Act authorizes us to make rules and regulations and to
establish necessary and appropriate procedures to implement them.\6\
---------------------------------------------------------------------------
\6\ 42 U.S.C. 405(a), 902(a)(5), and 1383(d)(1).
---------------------------------------------------------------------------
When will we use this final rule?
We will begin to use this final rule on its effective date. We will
continue to use the current listings until the date this final rule
becomes effective. We will apply the final rule to new applications
filed on or after the effective date of the final rule and to claims
that are pending on or after the effective date.\7\
---------------------------------------------------------------------------
\7\ This means that we will use this final rule on and after its
effective date in any case in which we make a determination or
decision. We expect that Federal courts will review our final
decisions using the rule that was in effect at the time we issued
the decisions. If a court reverses our final decision and remands a
case for further administrative proceedings after the effective date
of this final rule, we will apply this final rule to the entire
period at issue in the decision we make after the court's remand.
---------------------------------------------------------------------------
How long will this final rule be effective?
This final rule will remain in effect for 5 years after the date it
becomes effective, unless we extend it or revise and issue it again.
Regulatory Procedures
Executive Order 12866, as Supplemented by Executive Order 13563
We consulted with the Office of Management and Budget (OMB) and
determined that this final rule meets the criteria for a significant
regulatory action under Executive Order 12866, as supplemented by
Executive Order 13563. Therefore, OMB reviewed this final rule.
Regulatory Flexibility Act
We certify that this final rule would not have a significant
economic impact on a substantial number of small entities because they
affect individuals only. Therefore, a regulatory flexibility analysis
is not required under the Regulatory Flexibility Act, as amended.
Paperwork Reduction Act
This final rule does not create any new or affect any existing
collections and, therefore, does not require OMB approval under the
Paperwork Reduction Act.
(Catalog of Federal Domestic Assistance Program Nos. 96.001, Social
Security--Disability Insurance; 96.002, Social Security--Retirement
Insurance; 96.004, Social Security--Survivors Insurance; and 96.006,
Supplemental Security Income).
List of Subjects
20 CFR Part 404
Administrative practice and procedure; Blind, Disability benefits;
Old-Age, Survivors, and Disability Insurance; Reporting and
recordkeeping requirements; Social Security.
20 CFR Part 416
Administrative practice and procedure; Aged, Blind, Disability
benefits; Public assistance programs; Reporting and recordkeeping
requirements; Supplemental Security Income (SSI).
Carolyn W. Colvin,
Acting Commissioner of Social Security.
For the reasons set out in the preamble, we are amending 20 CFR
part 404 subpart P and part 416 subpart I as set forth below:
PART 404--FEDERAL OLD-AGE, SURVIVORS AND DISABILITY INSURANCE
(1950-)
0
1. The authority citation for subpart P of part 404 continues to read
as follows:
Authority: Secs. 202, 205(a)-(b) and (d)-(h), 216(i), 221(a),
(i), and (j), 222(c), 223, 225, and 702(a)(5) of the Social Security
Act (42 U.S.C. 402, 405(a)-(b) and (d)-(h), 416(i), 421(a), (i), and
(j), 422(c), 423, 425, and 902(a)(5)); sec. 211(b), Pub. L. 104-193,
110 Stat. 2105, 2189; sec. 202, Pub. L. 108-203, 118 Stat. 509 (42
U.S.C. 902 note).
0
2. Amend appendix 1 to subpart P of part 404 as follows:
0
a. Revise item 1 of the introductory text before part A of appendix 1.
0
b. Amend part B by revising the body system name for section 100.00 in
the table of contents.
0
c. Revise sections 100.00 and 100.01 of part B.
0
d. Remove sections 100.02 and 100.03 of part B.
0
e. Add sections 100.04 and 100.05 of part B
0
f. Add section 103.00F of part B.
0
g. Add listing 103.06 of part B.
0
h. Revise section 104.00C2b introductory text of part B.
0
i. Revise section 104.00C2b(ii) of part B.
0
j. Add section 104.00C3 of part B.
0
k. Revise listing 104.02C of part B.
0
l. Revise section 105.00G of part B.
0
m. Revise listing 105.08 of part B.
0
n. Redesignate section 106.00C5 of part B as 106.00C6 and add new
section 106.00C5.
0
o. Add listing 106.08 of part B.
0
p. Add section 114.00F4d of part B.
0
q. Revise listing 114.08H of part B.
The revisions and additions read as follows:
APPENDIX 1 TO SUBPART P OF PART 404--LISTING OF IMPAIRMENTS
* * * * *
1. Low Birth Weight and Failure to Thrive (100.00): June 12,
2020.
* * * * *
Part B
* * * * *
100.00 Low Birth Weight and Failure to Thrive.
* * * * *
100.00 LOW BIRTH WEIGHT AND FAILURE TO THRIVE
A. What conditions do we evaluate under these listings? We
evaluate low birth weight (LBW) in infants from birth to attainment
of age 1 and failure to thrive (FTT) in infants and toddlers from
birth to attainment of age 3.
B. How do we evaluate disability based on LBW under 100.04? In
100.04A and 100.04B, we use an infant's birth weight as documented
by an original or certified copy of the infant's birth certificate
or by a medical record signed by a physician. Birth weight means the
first weight recorded after birth. In 100.04B, gestational age is
the infant's age based on the date of conception as recorded in the
medical record. If the infant's impairment meets the requirements
for listing 100.04A or 100.04B, we will follow the rule in Sec.
416.990(b)(11) of this chapter.
C. How do we evaluate disability based on FTT under 100.05?
1. General. We establish FTT with or without a known cause when
we have documentation of an infant's or a toddler's growth failure
and developmental delay from an acceptable medical source(s) as
defined in Sec. 416.913(a) of this chapter. We require
documentation of growth measurements in 100.05A and developmental
delay described in 100.05B or 100.05C within the same consecutive
12-month period. The dates of developmental testing and reports may
be different from the dates of growth measurements. After the
attainment of age 3, we evaluate growth failure under the affected
body system(s).
2. Growth failure. Under 100.05A, we use the appropriate
table(s) under 105.08B in the digestive system to determine whether
a child's growth is less than the third percentile. The child does
not need to have a digestive disorder for purposes of 100.05.
a. For children from birth to attainment of age 2, we use the
weight-for-length table corresponding to the child's gender (Table I
or Table II).
b. For children age 2 to attainment of age 3, we use the body
mass index (BMI)-for-age table corresponding to the child's gender
(Table III or Table IV).
[[Page 19526]]
c. BMI is the ratio of a child's weight to the square of his or
her height. We calculate BMI using the formulas in 105.00G2c.
d. Growth measurements. The weight-for-length measurements for
children from birth to the attainment of age 2 and BMI-for-age
measurements for children age 2 to attainment of age 3 that are
required for this listing must be obtained within a 12-month period
and at least 60 days apart. If a child attains age 2 during the
evaluation period, additional measurements are not needed. Any
measurements taken before the child attains age 2 can be used to
evaluate the impairment under the appropriate listing for the
child's age. If the child attains age 3 during the evaluation
period, the measurements can be used to evaluate the impairment in
the affected body system.
3. Developmental delay.
a. Under 100.05B and C, we use reports from acceptable medical
sources to establish delay in a child's development.
b. Under 100.05B, we document the severity of developmental
delay with results from a standardized developmental assessment,
which compares a child's level of development to the level typically
expected for his or her chronological age. If the child was born
prematurely, we may use the corrected chronological age (CCA) for
comparison. (See Sec. 416.924b(b) of this chapter.) CCA is the
chronological age adjusted by a period of gestational prematurity.
CCA = (chronological age)--(number of weeks premature). Acceptable
medical sources or early intervention specialists, physical or
occupational therapists, and other sources may conduct standardized
developmental assessments and developmental screenings. The results
of these tests and screenings must be accompanied by a statement or
records from an acceptable medical source who established the child
has a developmental delay.
c. Under 100.05C, when there are no results from a standardized
developmental assessment in the case record, we need narrative
developmental reports from the child's medical sources in sufficient
detail to assess the severity of his or her developmental delay. A
narrative developmental report is based on clinical observations,
progress notes, and well-baby check-ups. To meet the requirements
for 100.05C, the report must include: The child's developmental
history; examination findings (with abnormal findings noted on
repeated examinations); and an overall assessment of the child's
development (that is, more than one or two isolated skills) by the
medical source. Some narrative developmental reports may include
results from developmental screening tests, which can identify a
child who is not developing or achieving skills within expected
timeframes. Although medical sources may refer to screening test
results as supporting evidence in the narrative developmental
report, screening test results alone cannot establish a diagnosis or
the severity of developmental delay.
D. How do we evaluate disorders that do not meet one of these
listings?
1. We may find infants disabled due to other disorders when
their birth weights are greater than 1200 grams but less than 2000
grams and their weight and gestational age do not meet listing
100.04. The most common disorders of prematurity and LBW include
retinopathy of prematurity (ROP), chronic lung disease of infancy
(CLD, previously known as bronchopulmonary dysplasia, or BPD),
intraventricular hemorrhage (IVH), necrotizing enterocolitis (NEC),
and periventricular leukomalacia (PVL). Other disorders include poor
nutrition and growth failure, hearing disorders, seizure disorders,
cerebral palsy, and developmental disorders. We evaluate these
disorders under the affected body systems.
2. We may evaluate infants and toddlers with growth failure that
is associated with a known medical disorder under the body system of
that medical disorder, for example, the respiratory or digestive
body systems.
3. If an infant or toddler has a severe medically determinable
impairment(s) that does not meet the criteria of any listing, we
must also consider whether the child has an impairment(s) that
medically equals a listing (see Sec. 416.926 of this chapter). If
the child's impairment(s) does not meet or medically equal a
listing, we will determine whether the child's impairment(s)
functionally equals the listings (see Sec. 416.926a of this
chapter) considering the factors in Sec. 416.924a of this chapter.
We use the rule in Sec. 416.994a of this chapter when we decide
whether a child continues to be disabled.
100.01 Category of Impairments, Low Birth Weight and Failure to Thrive
100.04 Low birth weight in infants from birth to attainment of
age 1.
A. Birth weight (see 100.00B) of less than 1200 grams.
OR
B. The following gestational age and birth weight:
------------------------------------------------------------------------
Gestational age (in weeks) Birth weight
------------------------------------------------------------------------
37-40............................... 2000 grams or less.
36.................................. 1875 grams or less.
35.................................. 1700 grams or less.
34.................................. 1500 grams or less.
33.................................. 1325 grams or less.
32.................................. 1250 grams or less.
------------------------------------------------------------------------
100.05 Failure to thrive in children from birth to attainment of
age 3 (see 100.00C), documented by A and B, or A and C.
A. Growth failure as required in 1 or 2:
1. For children from birth to attainment of age 2, three weight-
for-length measurements that are:
a. Within a consecutive 12-month period; and
b. At least 60 days apart; and
c. Less than the third percentile on the appropriate weight-for-
length table in listing 105.08B1; or
2. For children age 2 to attainment of age 3, three BMI-for-age
measurements that are:
a. Within a consecutive 12-month period; and
b. At least 60 days apart; and
c. Less than the third percentile on the appropriate BMI-for-age
table in listing 105.08B2.
AND
B. Developmental delay (see 100.00C1 and C3), established by an
acceptable medical source and documented by findings from one
current report of a standardized developmental assessment (see
100.00C3b) that:
1. Shows development not more than two-thirds of the level
typically expected for the child's age; or
2. Results in a valid score that is at least two standard
deviations below the mean.
OR
C. Developmental delay (see 100.00C3), established by an
acceptable medical source and documented by findings from two
narrative developmental reports (see 100.00C3c) that:
1. Are dated at least 120 days apart (see 100.00C1); and
2. Indicate current development not more than two-thirds of the
level typically expected for the child's age.
* * * * *
103.00 RESPIRATORY SYSTEM
* * * * *
F. How do we evaluate growth failure due to any chronic
respiratory disorder?
1. To evaluate growth failure due to any chronic respiratory
disorder, we require documentation of the oxygen supplementation
described in 103.06A and the growth measurements in 103.06B within
the same consecutive 12-month period. The dates of oxygen
supplementation may be different from the dates of growth
measurements.
2. Under 103.06B, we use the appropriate table(s) under 105.08B
in the digestive system to determine whether a child's growth is
less than the third percentile.
a. For children from birth to attainment of age 2, we use the
weight-for-length table corresponding to the child's gender (Table I
or Table II).
b. For children age 2 to attainment of age 18, we use the body
mass index (BMI)-for-age table corresponding to the child's gender
(Table III or Table IV).
c. BMI is the ratio of a child's weight to the square of his or
her height. We calculate BMI using the formulas in 105.00G2c.
* * * * *
103.06 Growth failure due to any chronic respiratory disorder
(see 103.00F), documented by:
A. Hypoxemia with the need for at least 1.0 L/min of oxygen
supplementation for at least 4 hours per day and for at least 90
consecutive days.
AND
B. Growth failure as required in 1 or 2:
1. For children from birth to attainment of age 2, three weight-
for-length measurements that are:
a. Within a consecutive 12-month period; and
b. At least 60 days apart; and
c. Less than the third percentile on the appropriate weight-for-
length table under 105.08B1; or
2. For children age 2 to attainment of age 18, three BMI-for-age
measurements that are:
[[Page 19527]]
a. Within a consecutive 12-month period; and
b. At least 60 days apart; and
c. Less than the third percentile on the appropriate BMI-for-age
table under 105.08B2.
* * * * *
104.00 CARDIOVASCULAR SYSTEM
* * * * *
C. Evaluating Chronic Heart Failure
* * * * *
2. What evidence of CHF do we need?
* * * * *
b. To establish that you have chronic heart failure, we require
that your medical history and physical examination describe
characteristic symptoms and signs of pulmonary or systemic
congestion or of limited cardiac output associated with abnormal
findings on appropriate medically acceptable imaging. When a
remediable factor, such as arrhythmia, triggers an acute episode of
heart failure, you may experience restored cardiac function, and a
chronic impairment may not be present.
* * * * *
(ii) During infancy, other manifestations of chronic heart
failure may include repeated lower respiratory tract infections.
* * * * *
3. How do we evaluate growth failure due to CHF?
a. To evaluate growth failure due to CHF, we require
documentation of the clinical findings of CHF described in 104.00C2
and the growth measurements in 104.02C within the same consecutive
12-month period. The dates of clinical findings may be different
from the dates of growth measurements.
b. Under 104.02C, we use the appropriate table(s) under 105.08B
in the digestive system to determine whether a child's growth is
less than the third percentile.
(i) For children from birth to attainment of age 2, we use the
weight-for-length table corresponding to the child's gender (Table I
or Table II).
(ii) For children age 2 to attainment of age 18, we use the body
mass index (BMI)-for-age table corresponding to the child's gender
(Table III or Table IV).
(iii) BMI is the ratio of a child's weight to the square of his
or her height. We calculate BMI using the formulas in 105.00G2c.
* * * * *
104.02 * * *
* * * * *
C. Growth failure as required in 1 or 2:
1. For children from birth to attainment of age 2, three weight-
for-length measurements that are:
a. Within a consecutive 12-month period; and
b. At least 60 days apart; and
c. Less than the third percentile on the appropriate weight-for-
length table under 105.08B1; or
2. For children age 2 to attainment of age 18, three BMI-for-age
measurements that are:
a. Within a consecutive 12-month period; and
b. At least 60 days apart; and
c. Less than the third percentile on the appropriate BMI-for-age
table under 105.08B2.
* * * * *
105.00 DIGESTIVE SYSTEM
* * * * *
G. How do we evaluate growth failure due to any digestive
disorder?
1. To evaluate growth failure due to any digestive disorder, we
require documentation of the laboratory findings of chronic
nutritional deficiency described in 105.08A and the growth
measurements in 105.08B within the same consecutive 12-month period.
The dates of laboratory findings may be different from the dates of
growth measurements.
2. Under 105.08B, we evaluate a child's growth failure by using
the appropriate table for age and gender.
a. For children from birth to attainment of age 2, we use the
weight-for-length table (see Table I or Table II).
b. For children age 2 to attainment of age 18, we use the body
mass index (BMI)-for-age table (see Tables III or IV).
c. BMI is the ratio of a child's weight to the square of the
child's height. We calculate BMI using one of the following
formulas:
English Formula
BMI = [Weight in Pounds/(Height in Inches x Height in Inches)] x
703
Metric Formulas
BMI = Weight in Kilograms/(Height in Meters x Height in Meters)
BMI = [Weight in Kilograms/(Height in Centimeters x Height in
Centimeters)] x 10,000
* * * * *
105.08 Growth failure due to any digestive disorder (see
105.00G), documented by A and B:
A. Chronic nutritional deficiency present on at least two
evaluations at least 60 days apart within a consecutive 12-month
period documented by one of the following:
1. Anemia with hemoglobin less than 10.0 g/dL; or
2. Serum albumin of 3.0 g/dL or less;
AND
B. Growth failure as required in 1 or 2:
1. For children from birth to attainment of age 2, three weight-
for-length measurements that are:
a. Within a 12-month period; and
b. At least 60 days apart; and
c. Less than the third percentile on Table I or Table II; or
Table I--Males Birth to Attainment of Age 2
[Third Percentile Values for Weight-for-Length]
--------------------------------------------------------------------------------------------------------------------------------------------------------
Weight Length Weight Length Weight
Length (centimeters) (kilograms) (centimeters) (kilograms) (centimeters) (kilograms)
--------------------------------------------------------------------------------------------------------------------------------------------------------
45.0.......................................................... 1.597 64.5 6.132 84.5 10.301
45.5.......................................................... 1.703 65.5 6.359 85.5 10.499
46.5.......................................................... 1.919 66.5 6.584 86.5 10.696
47.5.......................................................... 2.139 67.5 6.807 87.5 10.895
48.5.......................................................... 2.364 68.5 7.027 88.5 11.095
49.5.......................................................... 2.592 69.5 7.245 89.5 11.296
50.5.......................................................... 2.824 70.5 7.461 90.5 11.498
51.5.......................................................... 3.058 71.5 7.674 91.5 11.703
52.5.......................................................... 3.294 72.5 7.885 92.5 11.910
53.5.......................................................... 3.532 73.5 8.094 93.5 12.119
54.5.......................................................... 3.771 74.5 8.301 94.5 12.331
55.5.......................................................... 4.010 75.5 8.507 95.5 12.546
56.5.......................................................... 4.250 76.5 8.710 96.5 12.764
57.5.......................................................... 4.489 77.5 8.913 97.5 12.987
58.5.......................................................... 4.728 78.5 9.113 98.5 13.213
59.5.......................................................... 4.966 79.5 9.313 99.5 13.443
60.5.......................................................... 5.203 80.5 9.512 100.5 13.678
61.5.......................................................... 5.438 81.5 9.710 101.5 13.918
62.5.......................................................... 5.671 82.5 9.907 102.5 14.163
63.5.......................................................... 5.903 83.5 10.104 103.5 14.413
--------------------------------------------------------------------------------------------------------------------------------------------------------
[[Page 19528]]
Table II--Females Birth to Attainment of Age 2
[Third Percentile Values for Weight-for-Length]
--------------------------------------------------------------------------------------------------------------------------------------------------------
Weight Length Weight Length Weight
Length (centimeters) (kilograms) (centimeters) (kilograms) (centimeters) (kilograms)
--------------------------------------------------------------------------------------------------------------------------------------------------------
45.0.......................................................... 1.613 64.5 5.985 84.5 10.071
45.5.......................................................... 1.724 65.5 6.200 85.5 10.270
46.5.......................................................... 1.946 66.5 6.413 86.5 10.469
47.5.......................................................... 2.171 67.5 6.625 87.5 10.670
48.5.......................................................... 2.397 68.5 6.836 88.5 10.871
49.5.......................................................... 2.624 69.5 7.046 89.5 11.074
50.5.......................................................... 2.852 70.5 7.254 90.5 11.278
51.5.......................................................... 3.081 71.5 7.461 91.5 11.484
52.5.......................................................... 3.310 72.5 7.667 92.5 11.691
53.5.......................................................... 3.538 73.5 7.871 93.5 11.901
54.5.......................................................... 3.767 74.5 8.075 94.5 12.112
55.5.......................................................... 3.994 75.5 8.277 95.5 12.326
56.5.......................................................... 4.220 76.5 8.479 96.5 12.541
57.5.......................................................... 4.445 77.5 8.679 97.5 12.760
58.5.......................................................... 4.892 78.5 8.879 98.5 12.981
59.5.......................................................... 5.113 79.5 9.078 99.5 13.205
60.5.......................................................... 5.333 80.5 9.277 100.5 13.431
61.5.......................................................... 5.552 81.5 9.476 101.5 13.661
62.5.......................................................... 5.769 82.5 9.674 102.5 13.895
63.5.......................................................... 5.769 83.5 9.872 103.5 14.132
--------------------------------------------------------------------------------------------------------------------------------------------------------
2. For children age 2 to attainment of age 18, three BMI-for-age
measurements that are:
a. Within a consecutive 12-month period; and
b. At least 60 days apart; and
c. Less than the third percentile on Table III or Table IV.
Table III--Males Age 2 to Attainment of Age 18
[Third Percentile Values for BMI-for-Age]
----------------------------------------------------------------------------------------------------------------
Age (yrs. and Age (yrs. and
Age (yrs. and mos.) BMI mos.) BMI mos.) BMI
----------------------------------------------------------------------------------------------------------------
2.0 to 2.1............ 14.5 10.11 to 11.2 14.3 14.9 to 14.10 16.1
2.2 to 2.4............ 14.4 11.3 to 11.5 14.4 14.11 to 15.0 16.2
2.5 to 2.7............ 14.3 11.6 to 11.8 14.5 15.1 to 15.3 16.3
2.8 to 2.11........... 14.2 11.9 to 11.11 14.6 15.4 to 15.5 16.4
3.0 to 3.2............ 14.1 12.0 to 12.1 14.7 15.6 to 15.7 16.5
3.3 to 3.6............ 14.0 12.2 to 12.4 14.8 15.8 to 15.9 16.6
3.7 to 3.11........... 13.9 12.5 to 12.7 14.9 15.10 to 15.11 16.7
4.0 to 4.5............ 13.8 12.8 to 12.9 15.0 16.0 to 16.1 16.8
4.6 to 5.0............ 13.7 12.10 to 13.0 15.1 16.2 to 16.3 16.9
5.1 to 6.0............ 13.6 13.1 to 13.2 15.2 16.4 to 16.5 17.0
6.1 to 7.6............ 13.5 13.3 to 13.4 15.3 16.6 to 16.8 17.1
7.7 to 8.6............ 13.6 13.5 to 13.7 15.4 16.9 to 16.10 17.2
8.7 to 9.1............ 13.7 13.8 to 13.9 15.5 16.11 to 17.0 17.3
9.2 to 9.6............ 13.8 13.10 to 13.11 15.6 17.1 to 17.2 17.4
9.7 to 9.11........... 13.9 14.0 to 14.1 15.7 17.3 to 17.5 17.5
10.0 to 10.3.......... 14.0 14.2 to 14.4 15.8 17.6 to 17.7 17.6
10.4 to 10.7.......... 14.1 14.5 to 14.6 15.9 17.8 to 17.9 17.7
10.8 to 10.10......... 14.2 14.7 to 14.8 16.0 17.10 to 17.11 17.8
----------------------------------------------------------------------------------------------------------------
Table IV--Females Age 2 to Attainment of Age 18
[Third Percentile Values for BMI-for-Age]
----------------------------------------------------------------------------------------------------------------
Age (yrs. and Age (yrs. and
Age (yrs. and mos.) BMI mos.) BMI mos.) BMI
----------------------------------------------------------------------------------------------------------------
2.0 to 2.2....................................... 14.1 10.8 to 10.10 14.0 14.3 to 14.5 15.6
2.3 to 2.6....................................... 14.0 10.11 to 11.2 14.1 14.6 to 14.7 15.7
2.7 to 2.10...................................... 13.9 11.3 to 11.5 14.2 14.8 to 14.9 15.8
2.11 to 3.2...................................... 13.8 11.6 to 11.7 14.3 14.10 to 15.0 15.9
3.3 to 3.6....................................... 13.7 11.8 to 11.10 14.4 15.1 to 15.2 16.0
3.7 to 3.11...................................... 13.6 11.11 to 12.1 14.5 15.3 to 15.5 16.1
4.0 to 4.4....................................... 13.5 12.2 to 12.4 14.6 15.6 to 15.7 16.2
4.5 to 4.11...................................... 13.4 12.5 to 12.6 14.7 15.8 to 15.10 16.3
5.0 to 5.9....................................... 13.3 12.7 to 12.9 14.8 15.11 to 16.0 16.4
5.10 to 7.6...................................... 13.2 12.10 to 12.11 14.9 16.1 to 16.3 16.5
[[Page 19529]]
7.7 to 8.4....................................... 13.3 13.0 to 13.2 15.0 16.4 to 16.6 16.6
8.5 to 8.10...................................... 13.4 13.3 to 13.4 15.1 16.7 to 16.9 16.7
8.11 to 9.3...................................... 13.5 13.5 to 13.7 15.2 16.10 to 17.0 16.8
9.4 to 9.8....................................... 13.6 13.8 to 13.9 15.3 17.1 to 17.3 16.9
9.9 to 10.0...................................... 13.7 13.10 to 14.0 15.4 17.4 to 17.7 17.0
10.1 to 10.4..................................... 13.8 14.1 to 14.2 15.5 17.8 to 17.11 17.1
10.5 to 10.7..................................... 13.9
----------------------------------------------------------------------------------------------------------------
* * * * *
106.00 GENITOURINARY IMPAIRMENTS
* * * * *
C. What other factors do we consider when we evaluate your
genitourinary disorder?
* * * * *
5. Growth failure due to any chronic renal disease.
a. To evaluate growth failure due to any chronic renal disease,
we require documentation of the laboratory findings described in
106.08A and the growth measurements in 106.08B within the same
consecutive 12-month period. The dates of laboratory findings may be
different from the dates of growth measurements.
b. Under 106.08B, we use the appropriate table(s) under 105.08B
in the digestive system to determine whether a child's growth is
less than the third percentile.
(i) For children from birth to attainment of age 2, we use the
weight-for-length table corresponding to the child's gender (Table I
or Table II).
(ii) For children age 2 to attainment of age 18, we use the body
mass index (BMI)-for-age table corresponding to the child's gender
(Table III or Table IV).
(iii) BMI is the ratio of a child's weight to the square of his
or her height. We calculate BMI using the formulas in 105.00G2c.
* * * * *
106.08 Growth failure due to any chronic renal disease (see
106.00C5), with:
A. Serum creatinine of 2 mg/dL or greater, documented at least
two times within a consecutive 12-month period with at least 60 days
between measurements.
AND
B. Growth failure as required in 1 or 2:
1. For children from birth to attainment of age 2, three weight-
for-length measurements that are:
a. Within a consecutive 12-month period; and
b. At least 60 days apart; and
c. Less than the third percentile on the appropriate weight-for-
length table under 105.08B1; or
2. For children age 2 to attainment of age 18, three BMI-for-age
measurements that are:
a. Within a consecutive 12-month period; and
b. At least 60 days apart; and
c. Less than the third percentile on the appropriate BMI-for-age
table under 105.08B2.
* * * * *
114.00 IMMUNE SYSTEM DISORDERS
* * * * *
F. * * *
* * * * *
4. HIV infection manifestations specific to children.
* * * * *
d. Growth failure due to HIV immune suppression.
(i) To evaluate growth failure due to HIV immune suppression, we
require documentation of the laboratory values described in 114.08H1
and the growth measurements in 114.08H2 or 114.08H3 within the same
consecutive 12-month period. The dates of laboratory findings may be
different from the dates of growth measurements.
(ii) Under 114.08H2 and 114.08H3, we use the appropriate table
under 105.08B in the digestive system to determine whether a child's
growth is less than the third percentile.
(A) For children from birth to attainment of age 2, we use the
weight-for-length table corresponding to the child's gender (Table I
or Table II).
(B) For children age 2 to attainment of age 18, we use the body
mass index (BMI)-for-age table corresponding to the child's gender
(Table III or Table IV).
(C) BMI is the ratio of a child's weight to the square of his or
her height. We calculate BMI using the formulas in 105.00G2c.
* * * * *
114.08 * * *
* * * * *
H. Immune suppression and growth failure (see 114.00F4d)
documented by 1 and 2, or by 1 and 3.
1. CD4 measurement:
a. For children from birth to attainment of age 5, CD4
percentage of less than 20 percent; or
b. For children age 5 to attainment of age 18, absolute CD4
count of less than 200 cells/mm\3\, or CD4 percentage of less than
14 percent; and
2. For children from birth to attainment of age 2, three weight-
for-length measurements that are:
a. Within a consecutive 12-month period; and
b. At least 60 days apart; and
c. Less than the third percentile on the appropriate weight-for-
length table under 105.08B1; or
3. For children age 2 to attainment of age 18, three BMI-for-age
measurements that are:
a. Within a consecutive 12-month period; and
b. At least 60 days apart; and
c. Less than the third percentile on the appropriate BMI-for-age
table under 105.08B2.
* * * * *
PART 416--SUPPLEMENTAL SECURITY INCOME FOR THE AGED, BLIND, AND
DISABLED
Subpart I--[Amended]
0
3. The authority citation for subpart I of part 416 continues to read
as follows:
Authority: Secs. 221(m), 702(a)(5), 1611, 1614, 1619, 1631(a),
(c), (d)(1), and (p), and 1633 of the Social Security Act (42 U.S.C.
421(m), 902(a)(5), 1382, 1382c, 1382h, 1383(a), (c), (d)(1), and
(p), and 1383b); secs. 4(c) and 5, 6(c)-(e), 14(a), and 15, Pub. L.
98-460, 98 Stat. 1794, 1801, 1802, and 1808 (42 U.S.C. 421 note, 423
note, and 1382h note).
0
4. Amend Sec. 416.924b by revising paragraph (b) to read as follows:
Sec. 416.924b Age as a factor of evaluation in the sequential
evaluation process for children.
* * * * *
(b) Correcting chronological age of premature infants. We generally
use chronological age (a child's age based on birth date) when we
decide whether, or the extent to which, a physical or mental impairment
or combination of impairments causes functional limitations. However,
if you were born prematurely, we may consider you younger than your
chronological age when we evaluate your development. We may use a
``corrected'' chronological age (CCA); that is, your chronological age
adjusted by a period of gestational prematurity. We consider an infant
born at less than 37 weeks' gestation to be born prematurely.
(1) We compute your CCA by subtracting the number of weeks of
prematurity (the difference between 40 weeks of full-term gestation and
the number of actual weeks of gestation) from your chronological age.
For example, if your chronological age is 20
[[Page 19530]]
weeks but you were born at 32 weeks gestation (8 weeks premature), then
your CCA is 12 weeks.
(2) We evaluate developmental delay in a premature child until the
child's prematurity is no longer a relevant factor, generally no later
than about chronological age 2.
(i) If you have not attained age 1 and were born prematurely, we
will assess your development using your CCA.
(ii) If you are over age 1 and have a developmental delay, and
prematurity is still a relevant factor, we will decide whether to
correct your chronological age. We will base our decision on our
judgment and all the facts in your case. If we decide to correct your
chronological age, we may correct it by subtracting the full number of
weeks of prematurity or a lesser number of weeks. If your developmental
delay is the result of your medically determinable impairment(s) and is
not attributable to your prematurity, we will decide not to correct
your chronological age.
(3) Notwithstanding the provisions in paragraph (b)(1) of this
section, we will not compute a CCA if the medical evidence shows that
your treating source or other medical source has already taken your
prematurity into consideration in his or her assessment of your
development. We will not compute a CCA when we find you disabled under
listing 100.04 of the Listing of Impairments.
Sec. 416.926a [Amended]
0
5. Amend Sec. 416.926a by removing paragraphs (m)(6) and (m)(7) and
redesignating paragraph (m)(8) as (m)(6).
0
6. Amend Sec. 416.934 by adding paragraphs (j) and (k) to read as
follows:
Sec. 416.934 Impairments which may warrant a finding of presumptive
disability or presumptive blindness.
* * * * *
(j) Infants weighing less than 1200 grams at birth, until
attainment of 1 year of age.
(k) Infants weighing at least 1200 but less than 2000 grams at
birth, and who are small for gestational age, until attainment of 1
year of age. (Small for gestational age means a birth weight that is at
or more than 2 standard deviations below the mean or that is less than
the third growth percentile for the gestational age of the infant.)
[FR Doc. 2015-08185 Filed 4-10-15; 8:45 am]
BILLING CODE 4191-02-P